Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA)

[email protected]

USERN_GROUP_logo

Objective

-To provide the opportunity for junior delegates to start their research journey. -To provide a network for junior and senior researchers to share their ideas and start collaborative projects. -To link researchers from different parts of the world and remove borders in the scientific world. Individual membership is available through sending CV and motivation letters.

Definition

The immune system has a critical role in protecting individuals against infections, while the immune system seems to be affected in autoimmune diseases and cancers. NIIMA aims to expand interdisciplinary studies and translational research related to the immune system, immune-mediated diseases and therapies. During its 7 years of activity, NIIMA has made it to publish 876 documents that resulted in the H-index of 55 (according to Scopus, accessed August 2023). NIIMA members has contributed to the publication of 19 books with international publishers.

Group members

Founder

Nima Rezaei

Managing Director

Niloufar Yazdanpanah

Member

Paper

Emami S, Ziaee V, Rezaei A, Sadr M, Maddah M, Amirzargar AA, Rezaei N. IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A. Int J Rheum Dis. 2015 May 27. doi: 10.1111/1756-185X.12674.

NULL

Mahmoudi M, Rezaiemanesh A, Salmaninejad A, Harsini S, Poursani S, Bahrami T, Tahghighi F, Ziaee V, Rezaei N. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity. 2015 Nov;48(...

NULL

Koochakzadeh L, Hosseinverdi S, Hedayat M, Farahani F, Tofighi A, Eghbali M, Bidoki AZ, Izadyar M, Rahiminejad MS, Ramyar A, Aghamohammadi A, Rezaei N. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma. Allergol Immunopathol (...

NULL

Yousefi A, Mahmoudi E, Zare Bidoki A, Najmi Varzaneh F, Baradaran Noveiry B, Sadr M, Motamed F, Najafi M, Farahmand F, Rezaei N. IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2016 May;10(5):65...

NULL

Yousefi H, Aghamohammadi A, Rezaei N. Clinical recommendations for oral management of patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2016 Apr;12(4):359-60. doi: 10.1586/1744666X.2016.1145055.

NULL

Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Sodagari HR, Esfahani SA, Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2016 Jun...

NULL

Aflatounian M, Smith H, Farahani F, Tofighi Naeem A, Straatman-Iwanowska A, Zoghi S, Khatri U, Tajdini P, Fallahi GH, Gissen P, Rezaei N. Novel VIPAS39 mutation in a syndromic patient with arthrogryposis, renal tubular dysfunction and intrahepatic ch...

NULL

Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol. 2016 Mar;99:272-85. doi: 10.1016/j.critrevonc.2016.01.007.

NULL

Fallahi GH, Latifi S, Mahmoudi M, Kushki D, Haghhi Ashtiani MT, Morteza A, Rezaei N. Growth Status and Its Relationship with Serum Lipids and Albumin in Children with Cystic Fibrosis. Acta Med Iran. 2016 Apr;54(4):276-9.

NULL

Shafieyoun A, Moraveji S, Bashashati M, Rezaei N. Discs Large Homolog 5 (DLG5) Gene Polymorphism and Crohn's Disease: A Meta-Analysis of the Published Studies. Acta Med Iran. 2016 May;54(5):289-95.

NULL

Aryan Z, Aghamohammadi A, Rezaei N. Toward the stratification and personalization of common variable immunodeficiency treatment. Expert Opinion on Orphan Drugs. 2016;4(8):823-30.

NULL

Azizi G, Rezaei N, Kiaee F, Tavakolinia N, Yazdani R, Mirshafiey A, et al. T-cell abnormalities in common variable immunodeficiency. Journal of Investigational Allergology and Clinical Immunology. 2016;26(4):233-43

NULL

Eghbali M, Sadeghi-Shabestari M, Najmi Varzaneh F, Zare Bidoki A, Rezaei N. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature. Allergologia et Immunopathologia. 2015

NULL

Harsini S, Ziaee V, Tahghighi F, Mahmoudi M, Rezaei A, Soltani S, et al. Association of interleukin-2 and interferon-γ single nucleotide polymorphisms with Juvenile systemic lupus erythematosus. Allergologia et Immunopathologia. 2015

NULL

Javan MR, Aslani S, Zamani MR, Rostamnejad J, Asadi M, Farhoodi M, et al. Downregulation of immunosuppressive molecules, PD-1 and PD-L1 but not PD-L2, in the patients with multiple sclerosis. Iranian Journal of Allergy, Asthma and Immunology. 2016;15...

NULL

Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, et al. Association of Interleukin-2, but not Interferon-Gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergologia et Immunopathologia. 2015

NULL

Saghazadeh A, Esfahani SA, Rezaei N. Genetic polymorphisms and the adequacy of brain stimulation: state of the art. Expert Review of Neurotherapeutics. 2016;16(9):1043-54

NULL

Saghazadeh A, Ferrari CC, Rezaei N. Deciphering variability in the role of interleukin-1β in Parkinson's disease. Reviews in the Neurosciences. 2016;27(6):635-50

NULL

Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Critical reviews in oncology/hematology. 2016;99:272-85

NULL

Zamani MR, Salmaninejad A, Akbari Asbagh F, Masoud A, Rezaei N. STAT4 single nucleotide gene polymorphisms and susceptibility to endometriosis-related infertility. European Journal of Obstetrics Gynecology and Reproductive Biology. 2016;203:20-4

NULL

Ziaee V, Rezaei A, Harsini S, Maddah M, Zoghi S, Sadr M, et al. Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clinical rheumatology. 2016;35(8):1943-8

NULL

Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, Ziaee V, Rezaei N. Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population.Fetal Pediatr Pathol. 2016 Oct 12...

NULL

Ziaee V, Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Rezaei N. Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population. Allergol Immunopathol (Madr). 2016 Oct 4. pii: S0301-0...

NULL

Yazdani R, Seify R, Ganjalikhani-Hakemi M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, Ansaripour B, Salehi E, Azizi G, Rezaei N, Aghamohammadi A.Comparison of various classifications for patients with common variable immunodeficiency (CVID) using...

NULL

Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Immunol Invest. 2016 Oct;45(7):619-40. doi: 10.1080/08820139.2016...

NULL

Ziaee V, Maddah M, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Harsini S, Rezaei N.Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.Clin Rheumatol. 2016 Sep 20.DOI: 10.1007/s10067-016-3407-6

NULL

Zamani MR, Aslani S, Salmaninejad A, Javan MR, Rezaei N. PD-1/PD-L and autoimmunity: A growing relationship.Cell Immunol. 2016 Sep 15. pii: S0008-8749(16)30109-5. doi: 10.1016/j.cellimm.2016.09.009.

NULL

Eskian M, Khorasanizadeh M, Kraeber-Bodere F, Rezaei N.Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response. Crit Rev Oncol Hematol. 2016 Nov;107:182-189

NULL

Khodadad A, Aflatoonian M, Jalilian R, Babaei N, Motamed F, Ebrahime Soltani A, Rasoolzadeh B, Motavasselian F, Rezaei N.Comparison of Oral Midazolam With Intravenous Midazolam for Sedation Children During Upper Gastrointestinal Endoscopy. Acta Med I...

NULL

Namazi S, Tajik N, Ziaee V, Sadr M, Soltani S, Rezaei A, Zoghi S, Rezaei N. APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus.Clin Rheumatol. 2016 Nov 23.

NULL

Shokri S, Nabavi M, Hirschmugl T, Aghamohammadi A, Arshi S, Bemanian MH, Fallahpour M, Molatefi R, Rekabi M, Eslami N, Ahmadian J, Darabi K, Sedighi GR, Monajemzadeh M, Modaresi M, Parvaneh N, Boztug K, Rezaei N.LPS-Responsive Beige-Like Anchor Gene...

NULL

Firouze Moqadam I, Najafi S, Mohammadzadeh M, Zare Bidoki A, Yousefi H, Farhadi E, Tonekaboni A, Meighani G, Mohammadzadeh M, Amirzargar AA, Rezaei N. Lack of Association between Interleukin-12 Gene Polymorphisms and Recurrent Aphthous Stomatitis.Avi...

NULL

Javan MR, Aslani S, Zamani MR, Rostamnejad J, Asadi M, Farhoodi M, Nicknam MH.Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis.Iran J Allergy Asthma Immunol. 2016 Aug;15(4):296-302

NULL

Shabani M, Nichols KE, Rezaei N.Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders.Crit Rev Oncol Hematol. 2016 Dec;108:109-127

NULL

Maddah M, Harsini S, Ziaee V, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Aghighi Y, Rezaei N. Association of tumour necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis.Int J Immunogenet. 2016...

NULL

Alizadeh M, Ghasemi Hashtroodi L, Chavoshzadeh Z, Rezaei N. Effect of Air Pollution in Frequency of Hospitalizations in Asthmatic Children.Acta Med Iran. 2016 Aug;54(8):542-546.

NULL

Yazdani R, Ganjalikhani-Hakemi M, Esmaeili M, Abolhassani H, Vaeli S, Rezaei A, Sharifi Z, Azizi G, Rezaei N, Aghamohammadi A.Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency.Clin Immunol. 2016 Sep 21. pii: S1...

NULL

Assari R, Aghighi Y, Ziaee V, Sadr M, Rahmani F, Rezaei A, Sadr Z, Moradinejad MH, Raeeskarami SR, Rezaei N.Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease.Int J Rheum Dis. 2016 Jul 25.

NULL

Rahmani F, Rezaei N.Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis.Expert Rev Clin Immunol. 2016 Dec;12(12):1289-1298.

NULL

Khorasanizadeh M, Eskian M, Assa'ad AH, Camargo CA Jr, Rezaei N. Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma.Int Rev Immunol. 2016 Jul 3;35(4):294-311

NULL

Fazel A, Kashef S, Aleyasin S, Harsini S, Karamizadeh Z, Zoghi S, Flores SK, Boztug K, Rezaei N.Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.Allergol Immunopathol (Madr). 2017 Ja...

NULL

Assari R, Aghighi Y, Ziaee V,, Sadr M, Rezaei A, Rahmani F, Sadr Z, Raeeskarami SR, Moradinejad MH, Rezaei N.Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: a case-control study and a review of knowledge.Int J Rheum Dis. 2...

NULL

Aslani S, Mahmoudi M, Salmaninejad A, Poursani S, Ziaee V, Rezaei N. Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients.Fetal Pediatr Pathol. 2017 Mar 2:1-7. doi: 10.1080/15513815.2016...

NULL

Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, Kiaee F, Shaghaghi M, Mohammadi J, Rezaei N, Hammarström L, Aghamohammadi AClinical, Immunological, Molecular Analyses and Outcomes of Iranian Patients with LRBA Deficiency:...

Paper

Aflatounian M, Rezaei A, Sadr M, Saghazadeh A, Elhamian N, Sadeghi H, Motevasselian F, Farahmand F, Fallahi G, Motamed F, Najafi M, Rezaei N. Fetal Pediatr Pathol. 2017 May 8:1-8. doi: 10.1080/15513815.2017.1290725

NULL

Gholami K, Laali E, Abolhassani H, Ahmadvand A, Mohebbi N, Javadi MR, Aghamohammadi A, Rezaei N.Costs of Hospital Admission on Primary Immunodeficiency Diseases.

NULL

Abbasi F, Soltani S, Saghazadeh A, Soltaninejad E, Rezaei A, Zare Bidoki A, Bahrami T, Amirzargar AA, Rezaei N.PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus.Immunol Invest. 2017 May;46(4):409-418. doi: 10.10...

NULL

Aghamohammadi A, Abolhassani H, Puchalka J, Greif-Kohistani N, Zoghi S, Klein C, Rezaei N. Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome.J Clin Immunol. 2017 Apr;37(3):282-286. doi: 10.1007/s10875...

NULL

Saghazadeh A, Hafizi S, Hosseini F, Ashrafi MR, Rezaei N. Early-Onset Friedreich's Ataxia With Oculomotor Apraxia. Acta Med Iran. 2017 Feb;55(2):128-130.

NULL

Saghazadeh A, Rezaei N. Implications of Toll-like receptors in Ebola infection.

NULL

Mohammadzadeh I, Moazzami B, Ghaffari J, Aghamohammadi A, Rezaei N. Primary immunodeficiency diseases in Northern Iran.

NULL

Khorasanizadeh M, Eskian M, Gelfand EW, Rezaei N. Mitogen-activated protein kinases as therapeutic targets for asthma.

NULL

Masoud S, Rajabi G, Delavari F, Rezaei N. Evaluating Awareness of Pediatricians and General Practitioners on Transformation of the Health System in Iran. Acta Med Iran. 2017 Jan;55(1):49-52

NULL

Movahedi M, Tavakol M, Rahmani F, Amirzargar AA, Bidoki AZ, Heidari K, Gharagozlou M, Aghamohammadi A, Nabavi M, Soltani S, Rezaei N. Single nucleotide polymorphisms of IL-2, but not IL-12 and IFN-γ, are associated with increased susceptibility to ch...

NULL

Aryan Z, Rezaei N, Camargo CA Jr.Vitamin D status, aeroallergen sensitization, and allergic rhinitis: A systematic review and meta-analysis. Int Rev Immunol. 2017 Jan 2;36(1):41-53. doi: 10.1080/08830185.2016.1272600.

NULL

Yazdani R, Abolhassani H, Asgardoon M, Shaghaghi M, Modaresi M, Azizi G, Aghamohammadi A.Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders.J Investig Allergol Clin Immunol. 2017;27(4):213-224. do...

NULL

Khorasanizadeh M, Eskian M, Rezaei N.Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma.Acta Med Iran. 2017 May;55(5):352-353

NULL

Farrokhi S, Shabani M, Aryan Z, Zoghi S, Krolo A, Boztug K, Rezaei N.MHC class II deficiency: Report of a novel mutation and special review.Allergol Immunopathol (Madr). 2017 Jul 1. pii: S0301-0546(17)30077-0. doi: 10.1016/j.aller.2017.04.006

NULL

Eslami N, Tavakol M, Mesdaghi M, Gharegozlou M, Casanova JL, Puel A, Okada S, Arshi S, Bemanian MH, Fallahpour M, Molatefi R, Seif F, Zoghi S, Rezaei N, Nabavi M.A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic muc...

NULL

Motamed F, Bagherian R, Adalat G, Moradinejad MH, Hajizadeh N, Vasei M, Mehdizadeh M, Rezaei N.Systemic Amyloidosis in a Teenage Boy With Inflammatory Bowel Disease.Acta Med Iran. 2017 Apr;55(4):265-267.

NULL

Aslani S, Mahmoudi M, Salmaninejad A, Poursani S, Ziaee V, Rezaei N. Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients.Fetal Pediatr Pathol. 2017 Jun;36(3):177-183. doi: 10.1080/15513...

NULL

Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, Kiaee F, Shaghaghi M, Mohammadi J, Rezaei N, Hammarström L, Aghamohammadi A.Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A...

NULL

Aflatounian M, Rezaei A, Sadr M, Saghazadeh A, Elhamian N, Sadeghi H, Motevasselian F, Farahmand F, Fallahi G, Motamed F, Najafi M, Rezaei N.Association of PTPN22 Single Nucleotide Polymorphisms with Celiac Disease.Fetal Pediatr Pathol. 2017 Jun;36(3...

NULL

Gholami K, Laali E, Abolhassani H, Ahmadvand A, Mohebbi N, Javadi MR, Aghamohammadi A, Rezaei N.Costs of Hospital Admission on Primary Immunodeficiency Diseases.Iran J Public Health. 2017 Mar;46(3):342-350

NULL

Taher M, Ebrahimi Daryani N, Hedayat M, Eslamian M, Farhadi E, Mahmoudi M, Shirzad S, Nouri Taromlou MK, Chaharmahali M, Nicknam MH, Bashashati M, Rezaei N.Association analysis of RAC1 single nucleotide polymorphisms with ulcerative colitis.Clin Res...

NULL

Abbasi F, Soltani S, Saghazadeh A, Soltaninejad E, Rezaei A, Zare Bidoki A, Bahrami T, Amirzargar AA, Rezaei N.PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus.Immunol Invest. 2017 May;46(4):409-418. doi: 10.10...

NULL

Saghazadeh A, Hafizi S, Hosseini F, Ashrafi MR, Rezaei N.Early-Onset Friedreich's Ataxia With Oculomotor Apraxia.Acta Med Iran. 2017 Feb;55(2):128-130.

NULL

Saghazadeh A, Rezaei N.Implications of Toll-like receptors in Ebola infection.Expert Opin Ther Targets. 2017 Apr;21(4):415-425. doi: 10.1080/14728222.2017.1299128

NULL

Javan MR, Shahraki S, Safa A, Zamani MR, Salmaninejad A, Aslani S.An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple s...

NULL

Mohammadzadeh I, Moazzami B, Ghaffari J, Aghamohammadi A, Rezaei N.Primary immunodeficiency diseases in Northern Iran.Allergol Immunopathol (Madr). 2017 May - Jun;45(3):244-250. doi: 10.1016/j.aller.2016.11.001.

NULL

Khorasanizadeh M, Eskian M, Gelfand EW, Rezaei N.Primary immunodeficiency diseases in Northern Iran.Allergol Immunopathol (Madr). 2017 May - Jun;45(3):244-250. doi: 10.1016/j.aller.2016.11.001

NULL

Masoud S, Rajabi G, Delavari F, Rezaei N. Evaluating Awareness of Pediatricians and General Practitioners on Transformation of the Health System in Iran.Acta Med Iran. 2017 Jan;55(1):49-52.

NULL

Movahedi M, Tavakol M, Rahmani F, Amirzargar AA, Bidoki AZ, Heidari K, Gharagozlou M, Aghamohammadi A, Nabavi M, Soltani S, Rezaei N.Single nucleotide polymorphisms of IL-2, but not IL-12 and IFN-γ, are associated with increased susceptibility to chr...

NULL

Yousefi H, Yuan J, Keshavarz-Fathi M, Murphy JF, Rezaei N. Immunotherapy of cancers comes of age. Expert Rev Clin Immunol. 2017 Oct;13(10):1001-1015. doi: 10.1080/1744666X.2017.1366315.

NULL

Tavakolpour S, Mirsafaei HS, Elkaei Behjati S, Ghasemiadl M, Akhlaghdoust M, Sali S. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy. Immunol Lett. 2017 Oct;190...

NULL

Shahrokhi A, Zare-Shahabadi A, Naeimi Poor M, Sajedi F, Soltani S, Zoghi S, Shervin Badv R, Ashrafi MR, Rezaei N. Association of the Single Nucleotide Polymorphisms of the Genes Encoding IL-2 and IFN-γ With Febrile Seizure. Acta Med Iran. 2017 Jun;55...

NULL

Ebrahimi Daryani N, Saghazadeh A, Moossavi S, Sadr M, Shahkarami S, Soltani S, Farhadi E, Rezaei N. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease. Immunol Invest. 2017 Oct;46(7):714-729. doi: 10.1080...

NULL

Youssefian L, Vahidnezhad H, Saeidian AH, Sotoudeh S, Mahmoudi H, Daneshpazhooh M, Aghazadeh N, Adams R, Ghanadan A, Zeinali S, Fortina P, Uitto J. Autosomal recessive congenital ichthyosis: CERS3 mutations identified by a next generation sequencing...

NULL

Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart fail...

NULL

Shariat M, Abedinia N, Rezaei N, Farrokhzad N. Increase Concentration of Transforming Growth Factor Beta (TGF-β) in Breast Milk of Mothers With Psychological Disorders. Acta Med Iran. 2017 Jul;55(7):429-436.

NULL

Najafi S, Yousefi H, Mohammadzadeh M, Bidoki AZ, Farhadi E, Rezaei N. Interleukin-2, Interferon-gamma Gene Polymorphisms in Recurrent Aphthous Stomatitis. Prague Med Rep. 2017;118(2-3):81-86. doi: 10.14712/23362936.2017.7.

NULL

Rezaei S, Rezaei N, Mahmoudi M, Aryan Z. Is there sufficient evidence to support the use of vitamin supplements in the asthmatic patient? Expert Rev Respir Med. 2017 Nov;11(11):851-853. doi: 10.1080/17476348.2017.1383897.

NULL

Roozbehkia M, Mahmoudi M, Aletaha S, Rezaei N, Fattahi MJ, Jafarnezhad-Ansariha F, Barati A, Mirshafiey A. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylit...

NULL

Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. Ataxia telangiectasia syndrome: moonlighting ATM. Expert Rev Clin Immunol. 2017 Dec;13(12):1155-1172. doi: 10.1080/1744666X.2017.1392856.

NULL

Hanaei S, Sadr M, Rezaei A, Shahkarami S, Ebrahimi Daryani N, Bidoki AZ, Rezaei N. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):269-275. doi: 10.101...

NULL

Ebrahimiyan H, Aslani S, Rezaei N, Jamshidi A, Mahmoudi M. Survivin and autoimmunity; the ins and outs. Immunol Lett. 2018 Jan;193:14-24. doi: 10.1016/j.imlet.2017.11.004.

NULL

Kordjazy N, Haj-Mirzaian A, Haj-Mirzaian A, Rohani MM, Gelfand EW, Rezaei N, Abdolghaffari AH. Role of toll-like receptors in inflammatory bowel disease. Pharmacol Res. 2018 Mar;129:204-215. doi: 10.1016/j.phrs.2017.11.017.

NULL

Sukalo M, Schäflein E, Schanze I, Everman DB, Rezaei N, Argente J, Lorda-Sanchez I, Deshpande C, Takahashi T, Kleger A, Zenker M. Expanding the mutational spectrum in Johanson-Blizzard syndrome: identification of whole exon deletions and duplication...

NULL

Mahmoudi M, Aslani S, Hamzeh E, Ziaee V, Poursani S, Nicknam MH, Rezaei N. Association Study of MECP2 Gene Single Nucleotide Polymorphisms in Juvenile-Onset Systemic Lupus Erythematosus Patients from Iran. Fetal Pediatr Pathol. 2017 Dec;36(6):423-431...

NULL

Sotoudeh A, Rostami P, Nakhaeimoghadam M, Mohsenipour R, Rezaei N. Pericentric Inversion of Chromosome 9 in an Infant With Ambiguous Genitalia. Acta Med Iran. 2017 Oct;55(10):655-657.

NULL

Rezaei N, Saghazadeh A. The Role of PIEZO2 in Human Mechanosensation. Acta Med Iran. 2017 Oct;55(10):664

NULL

Eskian M, Khorasanizadeh M, Assa'ad AH, Rezaei N. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis. Clin Rev Allergy Immunol. 2018 Aug;55(1):88-98. doi: 10.1007/s12016-017-8659-7.

NULL

Khajeh Alizadeh Attar M, Anwar MA, Eskian M, Keshavarz-Fathi M, Choi S, Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis. Med Res Rev. 2018 Sep;38(5):1469-1484. doi:...

NULL

Yousefi A, Mahmoudi E, Baradaran Noveiry B, Zare Bidoki A, Sadr M, Motamed F, Najafi M, Farahmand F, Khodadad A, Fallahi GH, Rezaei N. Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma. C...

NULL

Mahmoudi M, Hamzeh E, Aslani S, Ziaee V, Poursani S, Rezaei N. Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis. Clin Rheumatol. 2018 Feb;37(2):375-381. doi: 10.1007/s10067-017-3968-z.

NULL

Najafi S, Mohammadzadeh M, Zahedi A, Heidari M, Rezaei N. Association of Serotonin Transporter Gene Polymorphism with Recurrent Aphthous Stomatitis. Avicenna J Med Biotechnol. 2018 Jan-Mar;10(1):56-60.

NULL

Yousefi H, Najafi S, Mohammadzadeh M, Zare Bidoki A, Farhadi E, Rezaei N. Association of Transforming Growth Factor-Beta Gene Polymorphisms in Recurrent Aphthous Stomatitis. Acta Med Iran. 2017 Nov;55(11):672-675.

NULL

Mahmoudi M, Rezaiemanesh A, Harsini S, Salmaninejad A, Poursani S, Bahrami T, Ziaee V, Rezaei N. PDCD1 Single Nucleotide Polymorphisms in Iranian Patients With Juvenile Idiopathic Arthritis. Acta Med Iran. 2017 Nov;55(11):676-682.

NULL

Behniafard N, Amirzargar AA, Gharagozlou M, Delavari F, Hosseinverdi S, Sotoudeh S, Farhadi E, Mahmoudi M, Khaledi M, Moghaddam ZG, Aghamohammadi A, Rezaei N. Single nucleotide polymorphisms of the genes encoding IL-10 and TGF-β1 in Iranian children...

NULL

Hanaei S, Afshari K, Hirbod-Mobarakeh A, Mohajer B, Amir Dastmalchi D, Rezaei N. Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis. Rev Neurosci. 2018 Jun 27;29(4):443-461. doi: 10.1515/revneuro-2017-005...

NULL

Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N. sICAM-1, sVCAM-1 and sE-Selectin Levels in Type 1 Diabetes. Fetal Pediatr Pathol. 2018 Feb;37(1):69-73. doi: 10.1080/15513815.2017.1405467.

NULL

Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Jafarnezhad-Ansariha F, Shaghaghi M, Mortazavi-Jahromi SS, Noorbakhsh F, Rezaei N, Aghamohammadi A. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodefi...

NULL

Agah E, Zardoui A, Saghazadeh A, Ahmadi M, Tafakhori A, Rezaei N. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis. PLoS One. 2018 Jan 18;13(1):e0190252. doi: 10.1371/journal.pone.0190252.

NULL

Rezaei S, Harsini S, Kavoosi M, Badv RS, Mahmoudi M. Efficacy of low glycemic index treatment in epileptic patients: a systematic review. Acta Neurol Belg. 2018 Sep;118(3):339-349. doi: 10.1007/s13760-018-0881-4.

NULL

Esmaeili Reykande S, Rezaei A, Sadr M, Shabani M, Najmi Varzaneh F, Ziaee V, Rezaei N. Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis. Clin Rheumatol. 2018 Oct;37(10):2661-2665. doi: 10.1007...

NULL

Zare Bidoki A, Massoud A, Najafi S, Mohammadzadeh M, Rezaei N. Autosomal dominant deficiency of the interleukin-17F in recurrent aphthous stomatitis: Possible novel mutation in a new entity. Gene. 2018 May 15;654:64-68. doi: 10.1016/j.gene.2018.02.04...

NULL

Amanat M, Salehi M, Rezaei N. Neurological and psychiatric disorders in psoriasis. Rev Neurosci. 2018 Sep 25;29(7):805-813. doi: 10.1515/revneuro-2017-0108.

NULL

Azizi G, Abolhassani H, Zaki-Dizaji M, Habibi S, Mohammadi H, Shaghaghi M, Yazdani R, Anaya JM, Rezaei N, Hammarström L, Aghamohammadi A. Polyautoimmunity in Patients with LPS-Responsive Beige-Like Anchor (LRBA) Deficiency. Immunol Invest. 2018 Jul;4...

NULL

Eskian M, Khorasanizadeh M, Zinzani PL, Rezaei N. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy. 2018 Jun;10(8):699-711. doi: 10.2217/imt-2017-0169.

NULL

Rashid Chehreh Bargh S, Tafakhori A, Masoumi F, Rahmani F, Ahmadi M, Namdar A, Azimi M, Tavasolian P, Habibi S, Zamani B, Maserrat M, Sadr M, Noorbakhsh F, Rezaei N. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in periph...

NULL

Sanaei R, Rezaei N, Aghamohammadi A, Delbandi AA, Teimourian S, Yazdani R, Tavasolian P, Kiaee F, Tajik N. Evaluation of the TLR negative regulatory network in CVID patients. Genes Immun. 2019 Mar;20(3):198-206. doi: 10.1038/s41435-018-0022-3.

NULL

Zoghi S, Ziaee V, Hirschmugl T, Jimenez-Heredia R, Krolo A, Boztug K, Rezaei N. Exome sequencing revealed C1Q homozygous mutation in Pediatric Systemic Lupus Erythematosus. Allergol Immunopathol (Madr). 2018 Nov - Dec;46(6):594-598. doi: 10.1016/j.al...

NULL

Harsini S, Saghazadeh A, Nedjat S, Rezaei N. Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: a systematic review and meta-analysis. Eur Cytokine Netw. 2018 Mar 1;29(1):16-26. doi: 10.1684/ecn.201...

NULL

Sharifi L, Aghamohammadi A, Rezaei N, Yazdani R, Mahmoudi M, Amiri MM, Masoumi F, Bokaie S, Tavasolian P, Sanaei R, Moshiri M, Tavakolinia N, Alinia T, Azizi G, Mirshafiey A. The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downst...

NULL

Fallah S, Mesdaghi M, Mansouri M, Babaei D, Karimi A, Fahimzad SA, Armin S, Rafiei Tabatabaei S, Azma R, Khanbabaee G, Bashardoost B, Amirmoeini M, Sadr S, Jalilianhasanpour R, Ghanaei R, Rezaei N, Chavoshzadeh Z. Severe Combined Immunodeficiency: A...

NULL

Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018 Nov;179(5):1033-1048. doi: 10.1111/bjd.16808.

NULL

Hedayat M, Mahmoudi MJ, Taghvaei M, Nematipour E, Farhadi E, Esfahanian N, Mahmoudi M, Sadr M, Nourijelyani K, Amirzargar AA, Rezaei N. Tumor Necrosis Factor-Alpha and Interleukin-6 Gene Polymorphisms in Iranian Patients with Ischemic Heart Failure....

NULL

Fathollahi A, Aslani S, Mostafaei S, Rezaei N, Mahmoudi M. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis. Inflamm Res. 2018 Sep;67(9):727-736. doi...

NULL

Shabaninejad H, Asgharzadeh A, Rezapour A, Rezaei N. Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies. Med J Islam Repub Iran. 2017 Dec 17;31:94. doi: 10.14196/mjiri.31...

NULL

Béziat V, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956.

NULL

Shaghaghi M, Irannejad M, Abolhassani H, Shahmahmoodi S, Hamidieh AA, Soleyman-Jahi S, Yazdani R, Azizi G, Aghamohammadi A. Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of L...

NULL

Najafi S, Mohammadzadeh M, Rajabi F, Zare Bidoki A, Yousefi H, Farhadi E, Rezaei N. Interleukin-4 and Interleukin-4 Receptor Alpha Gene Polymorphisms in Recurrent Aphthous Stomatitis. Immunol Invest. 2018 Oct;47(7):680-688. doi: 10.1080/08820139.2018...

NULL

Mahmoudi MJ, Harsini S, Farhadi E, Hedayat M, Taghvaei M, Mahmoudi M, Sadr M, Esfahanian N, Nematipour E, Nourijelyani K, Amirzargar AA, Rezaei N. Interleukin-2 and Interferon-Gamma Single Nucleotide Polymorphisms in Iranian Patients with Chronic Hea...

NULL

Abdollahzade S, Hanaei S, Sadr M, Mirbolouk MH, Fattahi E, Rezaei N, Khoshnevisan A. Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian populati...

NULL

Farzaei MH, El-Senduny FF, Momtaz S, Parvizi F, Iranpanah A, Tewari D, Naseri R, Abdolghaffari AH, Rezaei N. An update on dietary consideration in inflammatory bowel disease: anthocyanins and more. Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):10...

NULL

Eskian M, Khorasanizadeh M, Isidori A, Rezaei N. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma. Int J Hematol Oncol. 2018 Jun 13;7(1):IJH01. doi: 10.2217/ijh-2017-0025.

NULL

Sodagari HR, Aryan Z, Abdolghaffari AH, Rezaei N, Sahebkar A. Immunomodulatory and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease (IBD): - Turning Strong Rationale into Strong Evidence? J Pharmacopuncture. 2018 Dec;2...

NULL

Tavasolian P, Sharifi L, Aghamohammadi A, Noorbakhsh F, Sanaei R, Shabani M, Rezaei N. Toll-like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA). Eur Cytokine Netw. 2018 Nov 1;29(4):153-158. doi: 10...

NULL

Farajifard H, Zavvar M, Rajaei T, Noorbakhsh F, Nikougoftar-Zarif M, Azadmanesh K, Kompani F, Rezaei N. In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia.Eur Cytokine Netw. 2018 N...

NULL

Mahmoudi M, Rezaei N. Nutrition and Immunity, 2019, Springer (ISBN 978-3-030-16072-2)

NULL

Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149-162. doi:10.1016/j.critrevonc.2018.10.003

NULL

Eskian M, Alavi A, Khorasanizadeh M, et al. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46(1):224...

NULL

Pastaki Khoshbin A, Eskian M, Keshavarz-Fathi M, Rezaei N. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond. Arch Immunol Ther Exp (Warsz). 2019;67(2):89-102. doi:10.1007/s00005-018-0531-9

NULL

Bagheri Y, Sanaei R, Yazdani R, et al. The Heterogeneous Pathogenesis of Selective Immunoglobulin A Deficiency. Int Arch Allergy Immunol. 2019;179(3):231-246. doi:10.1159/000499044

NULL

Sadr M, Moazzami B, Soleimanifar N, et al. Single Nucleotide Polymorphisms of PTPN22 Gene in Iranian Patients with Ulcerative Colitis. Fetal Pediatr Pathol. 2019;38(1):8-13. doi:10.1080/15513815.2018.1543371

NULL

Shabani M, Aleyasin S, Kashef S, et al. A Novel Recessive Mutation of Interferon-γ Receptor 1 in a Patient with Mycobacterium tuberculosis in Bone Marrow Aspirate. J Clin Immunol. 2019;39(2):127-130. doi:10.1007/s10875-019-00595-7

NULL

Razi B, Reykandeh SE, Alizadeh S, Amirzargar A, Saghazadeh A, Rezaei N. TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis. PLoS One. 2019;14(2):e0211146. Published 2019 Feb 7. doi:10.1371/jou...

NULL

Darbeheshti F, Rezaei N, Amoli MM, Mansoori Y, Tavakkoly Bazzaz J. Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactions. J Cell Physiol. 2019;234(12)...

NULL

El-Sayed ZA, Abramova I, Aldave JC, et al. X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J. 2019;12(3):100018. Published 2019 Mar 22. doi:10.1016/j.waojou.2019.100018

NULL

Ebrahimiyan H, Rezaei N, Vojdanian M, Aslani S, Jamshidi A, Mahmoudi M. microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int J Rheum Dis. 2019;22(6):1107-1114. doi:10.1111/17...

NULL

Jabbari P, Hanaei S, Rezaei N. State of the art in immunotherapy of neuroblastoma. Immunotherapy. 2019;11(9):831-850. doi:10.2217/imt-2019-0018

NULL

Jabbari P, Rezaei N. Artificial intelligence and immunotherapy. Expert Rev Clin Immunol. 2019;15(7):689-691. doi:10.1080/1744666X.2019.1623670

NULL

Sanaei R, Rezaei N, Aghamohammadi A, Delbandi AA, Tavasolian P, Tajik N. Disturbed Transcription of TLRs' Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients. Immunol Invest. 2019;48(8):860-874...

NULL

Bahrami T, Valilou SF, Sadr M, et al. PTPN22 Gene Polymorphisms in Pediatric Systemic Lupus Erythematosus. Fetal Pediatr Pathol. 2020;39(1):13-20. doi:10.1080/15513815.2019.1630873

NULL

Valizadeh A, Sanaei R, Rezaei N, et al. Potential role of regulatory B cells in immunological diseases. Immunol Lett. 2019;215:48-59. doi:10.1016/j.imlet.2019.08.004

NULL

Rezaei A, Harsini S, Sadr M, Ziaee V, Rezaei N. Interleukin-23 receptor gene polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr). 2020;48(1):62-66. doi:10.1016/j.aller.2019.05.007

NULL

Rahmani F, Ziaee V, Assari R, et al. Interleukin 10 and Transforming Growth Factor Beta Polymorphisms as Risk Factors for Kawasaki Disease: A Case-Control Study and Meta-Analysis. Avicenna J Med Biotechnol. 2019;11(4):325-333.

NULL

Ghorbani M, Fekrvand S, Shahkarami S, et al. The evaluation of neutropenia in common variable immune deficiency patients. Expert Rev Clin Immunol. 2019;15(11):1225-1233. doi:10.1080/1744666X.2020.1677154

NULL

Aryan Z, Nabavi M, Shabani M, et al. Hypomorphic DOCK8 deletion causes hypereosinophilic syndrome. Pediatr Blood Cancer. 2020;67(2):e28084. doi:10.1002/pbc.28084

NULL

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 t...

NULL

Mahalleh M, Shabani M, Rayzan E, Rezaei N. Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML. Immunotherapy. 2019;11(18):1583-1600. doi:10.2217/imt-2019-0043

NULL

Sharifi L, Aghamohammadi A, Rezaei N, et al. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine. Eur Cytokine Netw. 2019;30(4):123-129. doi:10.1...

NULL

Gorji Z, Modaresi M, Yekanni-Nejad S, Rezaei N, Mahmoudi M. Comparing effects of low glycemic index/high-fat, high-calorie diet and high-fat, high-calorie diet on cytokine levels of patients with cystic fibrosis: A randomized controlled clinical tria...

NULL

Fekrvand S, Yazdani R, Olbrich P, et al. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review. J Allergy Clin Immunol Pract. 2020;8(4):1371-1386. doi:10.1016/j.jaip.2020.01.038

NULL

Sabahi M, Jabbari P, Alizadeh Haghighi M, et al. Proposing a tandem AND-gate CAR T cell targeting glioblastoma multiforme. Med Hypotheses. 2020;137:109559. doi:10.1016/j.mehy.2020.109559

NULL

Rayzan E, Pouladfar G, Parvaneh N, Shahrooei M, Aryan Z, Rezaei N. Novel CYBA mutation in a family with BCGitis. Acta Microbiol Immunol Hung. 2019;67(1):56-60. Published 2019 Dec 18. doi:10.1556/030.66.2019.043

NULL

Hanaei S, Abdollahzade S, Sadr M, et al. The role of interleukin 4 and IL-4RA in intervertebral disc degeneration: investigation of single nucleotide polymorphisms in genes and a systematic review & meta-analysis of IL-4 expression level. Br J Neuros...

NULL

Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry. 2019;10:892. Published 2019 Dec 6. doi:10.3389/fpsyt.2019.00892

NULL

Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms. Crit Rev Oncol Hematol. 2020;150:102945. doi:10.1016/j.critrevonc.2020.102945

NULL

Falsafi Z, Tafakhori A, Agah E, et al. Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial. J Neurol Sci. 2020;414:116844. doi:10.1016/j.jns.2020.116844

NULL

Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020;41(9):1106-1107. doi:10.1017/ice.2020.139

NULL

Jafari D, Noorbakhsh F, Delavari A, et al. Expression level of long noncoding RNA NKILAmiR103-miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer. J Res Med Sci. 2020;25:41. Published 2020...

NULL

Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020;16(5):465-470. doi:10.1080/1744666X.2020.1750954

NULL

Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being. J Clin Virol. 2020;126:104345. doi:10.1016/j.jcv.2020.104345

NULL

Taghavi-Farahabadi M, Mahmoudi M, Hashemi SM, Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020;83:106463. doi:10.1016/j.intimp.2020.106463

NULL

Saadati S, Eskandari V, Rahmani F, et al. Gene Expression and Levels of TGF-B in PBMC Is Associated with Severity of Symptoms in Chronic Heart Failure. Avicenna J Med Biotechnol. 2020;12(2):132-134.

NULL

Nouri-Vaskeh M, Alizadeh L. Fecal transmission in COVID-19: A potential shedding route [published online ahead of print, 2020 Apr 1]. J Med Virol. 2020;10.1002/jmv.25816. doi:10.1002/jmv.25816

NULL

Hanaei S, Sanati G, Sadr M, Salmanroghani R, Rezaei N. DNA methylation of SOCS3 in intestinal biopsy and peripheral blood samples of Iranian patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2020;32(4):540-541. doi:10.1097/MEG.0000000000...

NULL

Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 2020;31(4):453-456. doi:10.1515/revneuro-2020-0026

NULL

Jahanshahlu L, Rezaei N. Central Nervous System Involvement in COVID-19. Arch Med Res. 2020;51(7):721-722. doi:10.1016/j.arcmed.2020.05.016

NULL

Keshavarz-Fathi M, Sanati G, Sadr M, Mohebbi B, Ziaei V, Rezaei N. DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus [published online ahead of print, 2020 May 19]. Fetal Pediatr Pathol. 2020;1-10. doi:10.1080/15513815.2020.17...

NULL

Hanaei S, Abdollahzade S, Sadr M, et al. Lack of association between COL1A1 and COL9A2 single nucleotide polymorphisms and intervertebral disc degeneration [published online ahead of print, 2020 May 18]. Br J Neurosurg. 2020;1-3. doi:10.1080/02688697...

NULL

Hanaei S, Rezaei N. COVID-19: Developing from an Outbreak to A Pandemic. Arch Med Res. 2020;51(6):582-584. doi:10.1016/j.arcmed.2020.04.021

NULL

Bahrami A, Sayyahfar S, Soltani Z, Khodadost M, Moazzami B, Rezaei N. Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: A cross-sectional study in Ir...

NULL

Saghazadeh A, Rezaei N. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol. 2020;84:106560. doi:10.1016/j.intim...

NULL

Kaveh S, Hosseinifard H, Ghadimi N, Vojdanian M, Aryankhesal A. Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis. Clin Rheumatol. 2020;39(11):3261-3276. doi:10.1007/s10067-020-04948-1

NULL

Darbeheshti F, Rezaei N. Genetic predisposition models to COVID-19 infection. Med Hypotheses. 2020;142:109818. doi:10.1016/j.mehy.2020.109818

NULL

Atabati H, Esmaeili SA, Saburi E, et al. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies. J Cell Physiol. 2020;235(12):8925-8937. doi:10.1002/jcp.29737

NULL

Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-1797. doi:10.1002/cbin.11403

NULL

Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: Friend or foe?. Life Sci. 2020;256:117900. doi:10.1016/j.lfs.2020.117900

NULL

Khalili N, Nouri-Vaskeh M, Hasanpour Segherlou Z, et al. Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers. Life Sci. 2020;256:117865. doi:10.1016/j.lfs.2020.117865

NULL

Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020;31(2):44-49. doi:10.1684/ecn.2020.0448

NULL

Jabbari P, Jabbari F, Ebrahimi S, Rezaei N. COVID-19: A Chimera of Two Pandemics. Disaster Med Public Health Prep. 2020;14(3):e38-e39. doi:10.1017/dmp.2020.223

NULL

Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N. COVID-19 and picotechnology: Potential opportunities [published online ahead of print, 2020 Jun 1]. Med Hypotheses. 2020;144:109917. doi:10.1016/j.mehy.2020.109917

NULL

Yousefzadegan S, Rezaei N. Case Report: Death due to COVID-19 in Three Brothers. Am J Trop Med Hyg. 2020;102(6):1203-1204. doi:10.4269/ajtmh.20-0240

NULL

Nasab MG, Saghazadeh A, Rezaei N. SARS-CoV-2-A Tough Opponent for the Immune System. Arch Med Res. 2020;51(6):589-592. doi:10.1016/j.arcmed.2020.05.020

NULL

Hanaei S, Sanati G, Zoghi S, Gharibzadeh S, Ziaee V, Rezaei N. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol Immunopathol (Madr). 2020;48(4):332-338. doi:10.1016/j.aller.2020.03.014

NULL

Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254-266. doi:10.1016/j.cca.2020.05.044

NULL

Dooghaie Moghadam A, Eslami P, Razavi-Khorasani N, et al. The Impacts of the COVID-19 Pandemic on Liver Transplant Patients; Time to Change the Priorities. Arch Iran Med. 2020;23(7):507-508. Published 2020 Jul 1. doi:10.34172/aim.2020.50

NULL

Hatami F, Valizadeh N, Ansari Ramandi MM. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature. Anatol J Cardiol. 2020;24(1):7-12. doi:10.14744/AnatolJCardiol.2020.68166

NULL

Balibegloo M, Rezaei N. Development and clinical application of bispecific antibody in the treatment of colorectal cancer. Expert Rev Clin Immunol. 2020;16(7):689-709. doi:10.1080/1744666X.2020.1783249

NULL

Momtazmanesh S, Rayzan E, Shahkarami S, Rohlfs M, Klein C, Rezaei N. A novel VPS13B mutation in Cohen syndrome: a case report and review of literature. BMC Med Genet. 2020;21(1):140. Published 2020 Jun 30. doi:10.1186/s12881-020-01075-1

NULL

Mahdaviani SA, Mansouri D, Jamee M, et al. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. J Clin Immunol. 2020;40(6):872-882. doi:10.1007/s10875-020-00813-7

NULL

Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N. Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings?. Diabetes Res Clin Pract. 2020;166:108286. doi:10.1016/j.diabr...

NULL

Rzymski P, Nowicki M, Mullin GE, et al. Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol. 2020;86:106711. doi:10.1016/j.intimp.2020.106711

NULL

Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises [published online ahead of print, 2020 Jun 20]. Stem Cell Rev Rep. 2020;1-13. doi:10....

NULL

Jahanshahlu L, Rezaei N. Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother. 2020;129:110337. doi:10.1016/j.biopha.2020.110337

NULL

Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences [published online ahead of print, 2020 Jun 3]. J Med Virol. 2020;10.1002/jmv.26123. doi:10.1002/jmv.26123

NULL

Jabbari P, Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? [published online ahead of print, 2020 Jul 27]. Disaster Med Public Health Prep. 2020;1. doi:10.1017/dmp.2020.274

NULL

Naderi N, Ansari Ramandi MM, Baay M, et al. Cardiovascular patients in COVID-19 era, a case series, an experience from a tertiary cardiovascular center in Tehran, Iran [published online ahead of print, 2020 Jul 23]. Clin Case Rep. 2020;10.1002/ccr3.3...

NULL

Abdollahi Fakhim S, Nouri-Vaskeh M, Amiri F, Shahidi N. Comparison of two-flap palatoplasty plus intravelar veloplasty technique with and without double-layer Z-plasty on the soft palate length in children with cleft palate. Oral Maxillofac Surg. 202...

NULL

Shahrezaee M, Keshtkari S, Moradi-Lakeh M, et al. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017. Arch Osteoporos. 2020;15(1):103. Published 2020 Jul 10. doi:10.1007/s11657-020-007...

NULL

Salzer E, Zoghi S, Kiss MG, et al. The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity. Sci Immunol. 2020;5(49):eabc3979. doi:10.1126/sciimmunol.abc3979

NULL

Bahrami A, Vafapour M, Moazzami B, Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran [published online ahead of print, 2020 Jul 8]. J Paediatr Child...

NULL

Shabani M, Pazouki R, Parvin M, et al. Ocular Manifestations of Chronic Granulomatous Disease: First Report of Coats' Disease and Literature Review. J Clin Immunol. 2020;40(6):940-947. doi:10.1007/s10875-020-00810-w

NULL

Rahmani F, Rayzan E, Rahmani MR, et al. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR) [published online ahead of print, 2020 Jul 7]. Immuno...

NULL

Hanaei S, Abdollahzade S, Sadr M, et al. Association of interleukin 2, interleukin 12, and interferon-γ with intervertebral disc degeneration in Iranian population. BMC Med Genet. 2020;21(1):143. Published 2020 Jul 3. doi:10.1186/s12881-020-01081-3

NULL

Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic [published online ahead of print, 2020 Jul 3]. J Med Virol. 2020;10.1002/jmv.26251. doi:10.1002/jmv.26251

NULL

Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, Hashemi SM. Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity [published online ahead of print, 2020 Aug 11]. Immunol Invest. 2020...

NULL

Imanpour H, Rezaee H, Nouri-Vaskeh M. Angiotensin 1-7: A Novel Strategy in COVID-19 Treatment. Adv Pharm Bull. 2020;10(4):488-489. doi:10.34172/apb.2020.068

NULL

Sabourian R, Mirjalili SZ, Namini N, Chavoshy F, Hajimahmoodi M, Safavi M. HPLC methods for quantifying anticancer drugs in human samples: A systematic review. Anal Biochem. 2020;610:113891. doi:10.1016/j.ab.2020.113891

NULL

Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020;258:118185. doi:10.1016/j.lfs.2020.118185

NULL

Pourahmad R, Moazzami B, Rezaei N. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19 [published online ahead of print, 2020 Jul 31]. SN Compr Clin Med. 2020;1-5. doi:10.1007/s42399-020-00438-2

NULL

Hemmati S, Sadeghi MA, Yousefi-Manesh H, et al. Protective Effects of Leukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE): Possible Role of P47phox and MDA Downregulation. J Inflamm Res. 2020;13:411-420. Published...

NULL

Sharifkashani S, Bafrani MA, Khaboushan AS, et al. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol. 2020;884:173455. doi:10.1016/j.ejphar.2020.173455

NULL

Mobasheri T, Rayzan E, Shabani M, Hosseini M, Mahmoodi Chalbatani G, Rezaei N. Neuroblastoma-targeted nanoparticles and novel nanotechnology-based treatment methods [published online ahead of print, 2020 Jul 31]. J Cell Physiol. 2020;10.1002/jcp.2997...

NULL

Babaha F, Rezaei N. Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? [published online ahead of print, 2020 Jul 29]. Am J Med Sci. 2020;360(6):740-741. doi:10.1016/j.amjms.2020.07.027

NULL

Bahreini F, Rayzan E, Rezaei N. microRNA-related single-nucleotide polymorphisms and breast cancer [published online ahead of print, 2020 Jul 27]. J Cell Physiol. 2020;10.1002/jcp.29966. doi:10.1002/jcp.29966

NULL

Seyedpour S, Khodaei B, Loghman AH, et al. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies [published online ahead of print, 2020 Sep 9]. J Cell Physiol. 2020;10.1002/jcp.30032...

NULL

Sadeghmousavi S, Rezaei N. COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment [published online ahead of print, 2020 Sep 3]. SN Compr Clin Med. 2020;1-6. doi:10.1007/s42399-020-00504-9

NULL

Goudarzi S, Dehghani Firouzabadi F, Dehghani Firouzabadi M, Rezaei N. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2 [published online ahead of print, 2020 Sep 3]. Dermatol Ther. 2020;e14266. doi:10.1111/dth....

NULL

Seyran M, Pizzol D, Adadi P, et al. Questions concerning the proximal origin of SARS-CoV-2 [published online ahead of print, 2020 Sep 3]. J Med Virol. 2020;10.1002/jmv.26478. doi:10.1002/jmv.26478

NULL

Basiri A, Heidari A, Nadi MF, et al. Microfluidic devices for detection of RNA viruses [published online ahead of print, 2020 Aug 26]. Rev Med Virol. 2020;e2154. doi:10.1002/rmv.2154

NULL

Rokni M, Hamblin MR, Rezaei N. Cytokines and COVID-19: friends or foes?. Hum Vaccin Immunother. 2020;16(10):2363-2365. doi:10.1080/21645515.2020.1799669

NULL

Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep. 2020;14(1):134. Published 2020 Aug 24. doi:10.1186/s13256-020-02461-2

NULL

Momtazmanesh S, Perry G, Rezaei N. Toll-like receptors in Alzheimer's disease. J Neuroimmunol. 2020;348:577362. doi:10.1016/j.jneuroim.2020.577362

NULL

Infante M, Ricordi C, Alejandro R, Caprio M, Fabbri A. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection [published online ahead of print, 2020 Aug 16]. Expert Rev Anti Infect Ther....

NULL

Pashaei M, Rezaei N. Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther. 2020;20(10):1111-1116. doi:10.1080/14712598.2020.1807933

NULL

Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microbes New Infect. 2020;37:100743. doi:10.1016/j.nmni.2020.100743

NULL

Shojaeefar E, Malih N, Rezaei N. The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis [published online ahead of print, 2020 Sep 29]. Cell Biol Int. 2020;10.1002/cbin.11469. doi:10.1002/cbin.11469

NULL

Kappes L, Amer RL, Sommerlatte S, et al. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis. Sci Rep. 2020;10(1):15931. Published 2020 Sep 28. doi:10.1038/s41598-020-72960-1

NULL

Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases. J Immunol Res. 2020;2020:4873648. Published 2020 Sep 1...

NULL

Essouma M. Commentary to the article: Di D, Zhang L, Wu X, Leng R. Long-term exposure to outdoor air pollution and the risk of development of rheumatoid arthritis: a systematic review and meta-analysis. Semin arthritis rheum. 2020;50(2):266-275. Semi...

NULL

Lotfi M, Rezaei N. CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother. 2020;131:110738. doi:10.1016/j.biopha.2020.110738

NULL

Pezeshki S, Hemmati S, Rezaei N. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma. Expert Rev Anticancer Ther. 2020;20(10):819-822. doi:10.1080/14737140.2020.1812389

NULL

Mohamed K, Rezaei N. COVID-19 pandemic is not the time of trial and error [published online ahead of print, 2020 Sep 14]. Am J Emerg Med. 2020;S0735-6757(20)30814-7. doi:10.1016/j.ajem.2020.09.020

NULL

Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A. Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clin Neurol Neurosurg. 2020;198:106217. doi:10.1016/j.clineuro.2020.106217

NULL

Jabbari P, Taraghikhah N, Jabbari F, Ebrahimi S, Rezaei N. Adherence of the General Public to Self-protection Guidelines During the COVID-19 Pandemic [published online ahead of print, 2020 Nov 18]. Disaster Med Public Health Prep. 2020;1-12. doi:10.1...

NULL

Ebrahimi Meimand S, Rostam-Abadi Y, Rezaei N. Autism Spectrum Disorders and Natural Killer Cells: A Review on Pathogenesis and Treatment [published online ahead of print, 2020 Nov 15]. Expert Rev Clin Immunol. 2020;10.1080/1744666X.2020.1850273. doi:...

NULL

Yazdanpanah N, Saghazadeh A, Rezaei N. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. 2020;31(7):691-701. doi:10.1515/revneuro-2020-0039

NULL

Aleebrahim-Dehkordi E, Soveyzi F, Deravi N, Rabbani Z, Saghazadeh A, Rezaei N. Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children [published online ahead of print, 2020 Oct 22]. J Pediatr Nurs. 2020;56:70-79. doi:10.1016/j.pedn.2020.1...

NULL

Lundstrom K, Seyran M, Pizzol D, et al. Viewpoint: Origin of SARS-CoV-2. Viruses. 2020;12(11):E1203. Published 2020 Oct 22. doi:10.3390/v12111203

NULL

Nouri-Vaskeh M, Khalili N, Khalaji A, et al. Circulating glucagon-like peptide-1 level in patients with liver cirrhosis [published online ahead of print, 2020 Oct 12]. Arch Physiol Biochem. 2020;1-6. doi:10.1080/13813455.2020.1828479

NULL

Sarzaeim M, Rezaei N. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19 [published online ahead of print, 2020 Oct 6]. SN Compr Clin Med. 2020;1-6. doi:10.1007/s42399-020-00558-9

NULL

Sadeghmousavi S, Eskian M, Rahmani F, Rezaei N. The effect of insomnia on development of Alzheimer's disease. J Neuroinflammation. 2020;17(1):289. Published 2020 Oct 6. doi:10.1186/s12974-020-01960-9

NULL

Pourabdollah Toutkaboni M, Askari E, Khalili N, et al. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect. 2020;38:100777. doi:10.1016/j.nmni.2020.10077...

NULL

Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. Immune microenvironment in different molecular subtypes of ductal breast carcinoma [published online ahead of print, 2020 Oct 3]. Breast Cancer Res Treat. 2020;10.1007/s10549-020-05954-2. doi:10.1007/s10...

NULL

Vakhshoori M, Heidarpour M, Shafie D, Taheri M, Rezaei N, Sarrafzadegan N. Acute Cardiac Injury in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2020;23(11):801-812. Published 2020 Nov 1. doi:10.34172/aim.2020.107

NULL

Rezalotfi A, Vrynas AV, Dehghanian M, Rezaei N. Lessons from the Embryo: an Unrejected Transplant and a Benign Tumor [published online ahead of print, 2020 Nov 23]. Stem Cell Rev Rep. 2020;10.1007/s12015-020-10088-5. doi:10.1007/s12015-020-10088-5

NULL

Kawthar Mohamed, Niloufar Yazdanpanah, Amene Saghazadeh, Nima Rezaei, Computational Drug Discovery and Repurposing for the Treatment of COVID-19: A Systematic Review, Bioorganic Chemistry, 2020,104490, ISSN 0045-2068, https://doi.org/10.1016/j.bioorg...

NULL

Tantuoyir MM, Rezaei N. Serological Tests for COVID-19: Potential Opportunities [published online ahead of print, 2020 Dec 2]. Cell Biol Int. 2020;10.1002/cbin.11516. doi:10.1002/cbin.11516

NULL

Duarte-Silva E, Maes M, Macedo D, Savino W, Peixoto CA. Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder. Transl Psychiatry. 2020;10(1):419. Published 2020 Dec 2. doi:10.1038/s41398-020-01105-9

NULL

Khosroshahi LM, Rezaei N. Dysregulation of the Immune Response in COVID-19 [published online ahead of print, 2020 Dec 2]. Cell Biol Int. 2020;10.1002/cbin.11517. doi:10.1002/cbin.11517

NULL

Sadeghi Rad H, Bazaz SR, Monkman J, et al. The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. Clin Transl Immunology. 2020;9(11):e1215. Published 2020 Nov 22. doi:10.1002/cti2.1215

NULL

Seyran M, Takayama K, Uversky VN, et al. The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2† [published online ahead of print, 2020 Dec 2]. FEBS J. 2020;10.1111/febs.15651. doi:10.1111/febs.15651

NULL

Hassan, S.S.; Ghosh, S.; Attrish, D.; Choudhury, P.P.; Aljabali, A.A.A.; Uhal, B.D.; Lundstrom, K.; Rezaei, N.; Uversky, V.N.; Seyran, M.; Pizzol, D.; Adadi, P.; Soares, A.; El-Aziz, T.M.A.; Kandimalla, R.; Tambuwala, M.M.; Azad, G.K.; Sherchan, S.P....

NULL

Khedri M, Rezvantalab S, Maleki R, Rezaei N. Effect of ligand conjugation site on the micellization of Bio-Targeted PLGA-Based nanohybrids: A computational biology approach [published online ahead of print, 2020 Dec 18]. J Biomol Struct Dyn. 2020;1-1...

NULL

Etemadifar M, Ashourizadeh H, Nouri H, et al. MRI signs of CNS demyelinating diseases [published online ahead of print, 2020 Dec 4]. Mult Scler Relat Disord. 2020;47:102665. doi:10.1016/j.msard.2020.102665

NULL

Jenab, Y, Rezaei, N, Hedayat, B, Naderian, M, Shirani, S, Hosseini, K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID‐19. Clin Case Rep. 2020; 8: 2414– 2417. https://doi.org/10.1002/ccr3.3112

NULL

Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? [published online ahead of print, 2020 Oct 28]. Phytomedicine. 20...

NULL

Galeh SD, Nouri-Vaskeh M, Alipour M, Fakhim SA. Clinical and Demographical Characteristics of Cleft Lip and/or Palate in the Northwest of Iran: An Analysis of 1500 Patients [published online ahead of print, 2020 Dec 30]. Cleft Palate Craniofac J. 202...

NULL

Moradian N, Gouravani M, Salehi MA, et al. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw. 2020;31(3):81-93. doi:10.1684/ecn.2020.0451

NULL

Galeh SD, Nouri-Vaskeh M, Alipour M, Fakhim SA. Clinical and Demographical Characteristics of Cleft Lip and/or Palate in the Northwest of Iran: An Analysis of 1500 Patients. The Cleft Palate-Craniofacial Journal. December 2021. doi:10.1177/1055665620...

NULL

Jaseb, K, Nameh Goshay Fard, N, Rezaei, N, Sadeghian, S, Sadeghian, S. COVID‐19 in a case with Kikuchi‐Fujimoto disease. Clin Case Rep. 2021; 00: 1– 4. https://doi.org/10.1002/ccr3.3748

NULL

Rezaee H, Pourkarim F, Pourtaghi-Anvarian S, Entezari-Maleki T, Asvadi-Kermani T, Nouri-Vaskeh M. Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview. Pharmacol Res Perspect. 2021;9(1):e00705. doi:10.1002/prp2.7...

NULL

Khalili N, Mohammadzadeh I, Khalili N, et al. BCGitis as the primary manifestation of chronic granulomatous disease. IDCases. 2020;23:e01038. Published 2020 Dec 29. doi:10.1016/j.idcr.2020.e01038

NULL

Salehi M, Amanat M, Mohammadi M, et al. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis [published online ahead of print, 2021 Jan 2]. J Affect Disord. 2021;282:527-538...

NULL

Jabalameli N, Rajabi F, Firooz A, Rezaei N. The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases [published online ahead of print, 2021 Jan 26]. Immunol Invest. 2021;1-8. doi:10.1080/08820139.2021.1876086

NULL

Alimohammadi E, Nikzad A, Khedri M, et al. Potential treatment of Parkinson's disease using new-generation carbon nanotubes: a biomolecular in silico study [published online ahead of print, 2021 Jan 27]. Nanomedicine (Lond). 2021;10.2217/nnm-2020-037...

NULL

Khanmohammadi S, Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19 [published online ahead of print, 2021 Jan 28]. J Med Virol. 2021;10.1002/jmv.26826. doi:10.1002/jmv.26826

NULL

Zarandi PK, Zinatizadeh MR, Zinatizadeh M, Yousefi MH, Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments [published online ahead of print, 2021 Feb 2]. Biomed Pharmacother. 2021;137:111352. doi:10.1016/j.biopha.2021.11135...

NULL

Razavi A, Hamblin MR, Rezaei N. COVID-19 in patients with cancer: Risks and precautions [published online ahead of print, 2021 Jan 28]. Am J Emerg Med. 2021;S0735-6757(21)00070-X. doi:10.1016/j.ajem.2021.01.067

NULL

Pezeshki PS, Rezaei N. Immune Checkpoint Inhibition in COVID-19: Risks and Benefits [published online ahead of print, 2021 Feb 5]. Expert Opin Biol Ther. 2021;10.1080/14712598.2021.1887131. doi:10.1080/14712598.2021.1887131

NULL

Agah E, Nafissi S, Saleh F, et al. Investigating the possible association between NLRP3 gene polymorphisms and myasthenia gravis [published online ahead of print, 2021 Feb 3]. Muscle Nerve. 2021;10.1002/mus.27193. doi:10.1002/mus.27193

NULL

Peymani P, Dehesh T, Aligolighasemabadi F, et al. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun. 2021;6(1):3. doi:10.1186/s41231-021-00082-5

NULL

Vakili FG, Nouri-Vaskeh M, Eghbali E, Fakhim SA. Nasopharyngeal structure development in patients with cleft palate who underwent repair surgery [published online ahead of print, 2021 Jan 27]. J Stomatol Oral Maxillofac Surg. 2021;S2468-7855(21)00009...

NULL

Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk [published online ahead of print, 2020 Dec 23]. Rev Neurosci. 2020;10.1515/revneuro-2020-0066. doi:10.1515/revneuro-2020-0066

NULL

Hasanpour Segherlou Z, Nouri-Vaskeh M, Noroozi Guilandehi S, et al. GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme [published online ahead of print, 2021 Feb 12]. J Cell Physiol. 2021;10.1002/jcp.30289. doi:10...

NULL

Farmani AR, Nekoofar MH, Ebrahimi Barough S, et al. Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration [published online ahead of print, 2021 Feb 12]. Platelets. 2021;1-6. doi:10.1080/09537104.2020.1869710

NULL

Momtazmanesh S, Shobeiri P, Saghazadeh A, et al. Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis [published online ahead of print, 2021 Feb 16]. Rev Neurosci. 2021;10.1515/revneuro-2020-0145. doi:10.1515...

NULL

Infante M, Buoso A, Pieri M, et al. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study [published online ahead of print, 2021 Feb 18]. J Am Coll Nutr. 2021;1-16....

NULL

Godazandeh G, Shojaee L, Alizadeh-Navaei R, Hessami A. Corticosteroids in idiopathic granulomatous mastitis: a systematic review and meta-analysis [published online ahead of print, 2021 Feb 15]. Surg Today. 2021;10.1007/s00595-021-02234-4. doi:10.100...

NULL

Bahreini F, Rayzan E, Rezaei N. MicroRNAs and Diabetes Mellitus Type 1 [published online ahead of print, 2021 Feb 14]. Curr Diabetes Rev. 2021;10.2174/1573399817666210215111201. doi:10.2174/1573399817666210215111201

NULL

Hashemi A, Hashemi A, Ahmadieh A, Alizadehasl A, Ansari Ramandi MM. Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions. Case Rep Cardiol. 2021;2021:6688338. Published 2021 Feb 11. doi:10.1155/20...

NULL

Aghajanpoor Pasha M, Eslami P, Dooghaie Moghadam A, et al. The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients. Gastroenterol Hepatol Bed Bench. 2020;13(Suppl1):...

NULL

Nouri-Vaskeh M, Kalami N, Zand R, et al. Comparison of Losartan and Amlodipine Effects on the Outcomes of Patient with COVID-19 and Primary Hypertension: A Randomized Clinical Trial [published online ahead of print, 2021 Mar 1]. Int J Clin Pract. 202...

NULL

Zamani R, Shahkarami S, Rezaei N. Primary immunodeficiency associated with hypopigmentation: A differential diagnosis approach. Allergol Immunopathol (Madr). 2021;49(2):178-190. Published 2021 Mar 1. doi:10.15586/aei.v49i2.61

NULL

Sadr M, Khalili N, Mohebbi B, Mosharmovahed B, Afradi P, Rezaei N. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2021;49(2):40-45. Published 2021 Mar 1. doi:10.15586/aei.v49i2....

NULL

Maleki A, Khanmiri JM, Eshrat Abadi MK, et al. Innate lymphoid cell subsets and their cytokines in autoimmune diseases. Eur Cytokine Netw. 2020;31(4):118-128. doi:10.1684/ecn.2020.0460

NULL

Duarte-Silva E, Clarke G, Dinan TG, Peixoto CA. Personalized Nutrition for Depression: Impact on the Unholy Trinity [published online ahead of print, 2021 Mar 5]. Neuroimmunomodulation. 2021;1-5. doi:10.1159/000514094

NULL

Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? [published online ahead of print, 2021 Mar 9]. Int J Health Serv. 2021;20731421993940. doi:10.1177/0020731421993940

NULL

Sabahi M, Joshaghanian A, Dolatshahi M, Jabbari P, Rahmani F, Rezaei N. Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases [published online ahead of print, 2021 Mar 13]. J M...

NULL

Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19 [published online ahead of print, 2021 Mar 10]. Emergent Mater. 2021;1-20. doi:10.1007/s42247-021-00192-8

NULL

Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus [published online ahead of print, 2021 Mar 16]. Rev Med Virol. 2...

NULL

Amanat M, Rezaei N, Roozbeh M, et al. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol. 2021;21(1):116. Published 2021 Mar 16. doi:...

NULL

Roosta Y, Behzadi F, Askari E, Raeisi M, Danandeh Mehr A, Nouri-Vaskeh M. Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges. Leuk Res Rep. 2021;15:100239. doi:10.10...

NULL

Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes [published online ahead of print, 2021 Mar 20]. Int Immunopharm...

NULL

Ahmadi M, Pashangzadeh S, Mousavi P, et al. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19 [published online ahead of print, 2021 Mar 22]. Int Immunopharmacol. 2021;95:107568. doi:10.1016/j.intimp.2021.10756...

NULL

Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep. 2021;9(3):1279-1282. Published 2021 Jan 5. doi:10.1002/ccr3.3748

NULL

Jalalvand M, Darbeheshti F, Rezaei N. Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer [published online ahead of print, 2021 Mar 29]. Immunotherapy. 2021;10.2217/imt-2020-0283. doi:10.2217/imt-2020-0283

NULL

Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates [published online ahead of print, 2021 Apr 2]. Arch Gynecol Obstet. 2021;1-34. doi:10.1007/s00404-021-06049-z

NULL

Jabbari P, Sadeghalvad M, Rezaei N. An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammation [published online ahead of print, 2021 Apr 12]. Expert Opin Biol Ther. 2021;1-9. doi:10.1080/14712598.2021.1913118

NULL

Etemadifar M, Sedaghat N, Aghababaee A, et al. COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? [published online ahead of print, 2021 Mar 20]. Mult Scler Relat Disord. 2021;51:102915. doi:10.1016/j.m...

NULL

Seyran M, Hassan SS, Uversky VN, et al. Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks. Biomolecules. 2021;11(3):398. Published 2021 Mar 9. doi:10.3390/...

NULL

Sargazi S, Sheervalilou R, Rokni M, Shirvaliloo M, Shahraki O, Rezaei N. The role of autophagy in controlling of SARS-CoV-2 infection: An overview with virophagy-mediated of molecular drug targets [published online ahead of print, 2021 Apr 5]. Cell B...

NULL

Mojtabavi H, Fatehi F, Shahkarami S, Rezaei N, Nafissi S. Novel Mutations of the TYMP Gene in Mitochondrial Neurogastrointestinal Encephalomyopathy: Case Series and Literature Review [published online ahead of print, 2021 Apr 6]. J Mol Neurosci. 2021...

NULL

Mizandari M, Keshavarz P, Azrumelashvili T, et al. Left gastric artery embolization for obesity treatment: a systematic review and meta-analysis of human and animal studies [published online ahead of print, 2021 Apr 7]. Abdom Radiol (NY). 2021;10.100...

NULL

Essouma M, Noubiap JJ, Singwe-Ngandeu M, Hachulla E. Epidemiology of Idiopathic Inflammatory Myopathies in Africa: A Contemporary Systematic Review [published online ahead of print, 2021 Apr 9]. J Clin Rheumatol. 2021;10.1097/RHU.0000000000001736. do...

NULL

Hassan SS, Attrish D, Ghosh S, et al. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 [published online ahead of print, 2021 Apr 13]. Int J Biol Macromol. 2021;181:801-809. doi:10.1016/j.ijbiomac.2021.03.199

NULL

Pezeshki PS, Eskian M, Hamblin MR, Rezaei N. Immune checkpoint inhibition in classical Hodgkin lymphoma [published online ahead of print, 2021 Apr 15]. Expert Rev Anticancer Ther. 2021;10.1080/14737140.2021.1918548. doi:10.1080/14737140.2021.1918548

NULL

Hassan SS, Aljabali AAA, Panda PK, et al. A unique view of SARS-CoV-2 through the lens of ORF8 protein [published online ahead of print, 2021 Apr 15]. Comput Biol Med. 2021;133:104380. doi:10.1016/j.compbiomed.2021.104380

NULL

Sadri Nahand J, Shojaie L, Akhlagh SA, et al. Cell death pathways and viruses: Role of microRNAs. Mol Ther Nucleic Acids. 2021;24:487-511. Published 2021 Mar 19. doi:10.1016/j.omtn.2021.03.011

NULL

Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021;13(9):753-765. doi:10.2217/imt-2020-0349

NULL

Pourriyahi H, Saghazadeh A, Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities [published online ahead of print, 2021 Apr 16]. J Neuroimmunol. 2021;356:577578. doi:10.1016/j.jneuroim.2021.577578

NULL

Noori M, Nejadghaderi SA, Rezaei N. "Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants [published online ahead of print, 2021 May 3]. Infect Control Hosp Epidemiol. 2021;1-2. d...

NULL

Mansourabadi AH, Mohamed Khosroshahi L, Noorbakhsh F, Amirzargar A. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem ce...

NULL

Kadkhoda S, Darbeheshti F, Rezaei N, et al. Investigation of circRNA-miRNA-mRNA network in colorectal cancer using an integrative bioinformatics approach. Gastroenterol Hepatol Bed Bench. 2021;14(2):141-153.

NULL

Keshavarz P, Yazdanpanah F, Azhdari S, et al. Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome [published online ahead of print, 2021 May 10]. J Med Virol. 2021;10...

NULL

Sarvizadeh M, Hasanpour O, Naderi Ghale-Noie Z, et al. Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities. Front Oncol. 2021;11:650256. Published 2021 Apr 27. doi:10.3389/fonc.2021.650256

NULL

Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review [published online ahead of print, 2021 May 1]. Acad Radiol. 2021;S1076-6332(21)00196-3. doi:10.1016/j.acra.2021.04.007

NULL

Duarte-Silva E, Meiry da Rocha Araújo S, Oliveira WH, et al. Sildenafil Alleviates Murine Experimental Autoimmune Encephalomyelitis by Triggering Autophagy in the Spinal Cord. Front Immunol. 2021;12:671511. Published 2021 May 13. doi:10.3389/fimmu.20...

NULL

Farmani AR, Mahdavinezhad F, Moslemi R, et al. Anti-IgE monoclonal antibodies as potential treatment in COVID-19 [published online ahead of print, 2021 May 21]. Immunopharmacol Immunotoxicol. 2021;1-6. doi:10.1080/08923973.2021.1925906

NULL

Duarte-Silva E, de Melo MG, Maes M, Filho AJMC, Macedo D, Peixoto CA. Shared metabolic and neuroimmune mechanisms underlying Type 2 Diabetes Mellitus and Major Depressive Disorder [published online ahead of print, 2021 May 14]. Prog Neuropsychopharma...

NULL

Essouma M, Noubiap JJ. Outcomes of Pregnancy in Women With Idiopathic Inflammatory Myopathies in Africa [published online ahead of print, 2021 May 26]. Reumatol Clin. 2021;S1699-258X(21)00123-6. doi:10.1016/j.reuma.2021.04.005

NULL

Etemadifar M, Sigari AA, Sedaghat N, Salari M, Nouri H. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient [published online ahead of print, 2021 May 20]. Hum Vaccin Immunother. 2021;1...

NULL

Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review [published online ahead of print, 2021 Jun 4]. Rev Neurosci. 2021;10.1515/revneuro-202...

NULL

Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes [published online ahead of print, 2021 Jun 4]. Int Immunopharmacol. 2021;97:107823. doi:10.1016/j.intimp.2...

NULL

Jahromi AM, Khedri M, Ghasemi M, Omrani S, Maleki R, Rezaei N. Molecular insight into COF monolayers for urea sorption in artificial kidneys. Sci Rep. 2021;11(1):12085. Published 2021 Jun 8. doi:10.1038/s41598-021-91617-1

NULL

Saleki K, Yaribash S, Banazadeh M, et al. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies [published online ahead of print, 2021 Jun 11]. Eur J Pharmacol. 2021;174248. doi:10.101...

NULL

Darbeheshti F, Zokaei E, Mansoori Y, et al. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3. Cancer Cell Int. 2021;21(1):312. Published 2021 Jun 14. doi:10.1186/s12935-021...

NULL

Mousavi MJ, Farhadi E, Vodjgani M, et al. Role of Fibroblast Activation Protein Alpha in Fibroblast-like Synoviocytes of Rheumatoid Arthritis. Iran J Allergy Asthma Immunol. 2021;20(3):338-349. Published 2021 Jun 6. doi:10.18502/ijaai.v20i3.6335

NULL

Maroufi SF, Shaka Z, Mojtabavi H, et al. Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature [published online ahead of print, 2021 Jun 16]. Endocr Metab Immune Disord Drug Targets. 2021;10.2174/18...

NULL

Moeinafshar A, Hemmati S, Rezaei N. Immunotherapy in AML: a brief review on emerging strategies [published online ahead of print, 2021 Jun 23]. Clin Transl Oncol. 2021;10.1007/s12094-021-02662-1. doi:10.1007/s12094-021-02662-1

NULL

Balibegloo M, Nejadghaderi SA, Sadeghalvad M, et al. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis. Int Immunopharmacol. 2021;96:107796. doi:10.1016/j.intimp.2021.107...

NULL

Abadi B, Shahsavani Y, Faramarzpour M, Rezaei N, Rahimi HR. Antidepressants with Anti-Tumor Potential in Treating Glioblastoma: A Narrative Review [published online ahead of print, 2021 Jul 1]. Fundam Clin Pharmacol. 2021;10.1111/fcp.12712. doi:10.11...

NULL

Mousavi MJ, Shayesteh MRH, Jamalzehi S, et al. Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis. J Res Med Sci. 2021;26:22. Published 202...

NULL

Melika S, Hossein E, Mona S, et al. A novel homozygous RAG1 mutation is associated with severe combined immunodeficiency and neurological presentations. Allergol Immunopathol (Madr). 2021;49(4):91-97. Published 2021 Jul 1. doi:10.15586/aei.v49i4.194

NULL

Khan AS, Phelan JE, Khan MT, et al. Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. Sci Rep. 2021;11(1):14194. Published 2021 Jul 9. doi:10.1038/s41598-021-93501-4

NULL

Khanmohammadi S, Malekpour M, Jabbari P, Rezaei N. Genetic basis of Guillain-Barre syndrome [published online ahead of print, 2021 Jul 1]. J Neuroimmunol. 2021;358:577651. doi:10.1016/j.jneuroim.2021.577651

NULL

Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment [published online ahead of print, 2021 Jul 3]. Biomed Pharmacother. 2021;141:111875. doi:10.1016/...

NULL

Shabani M, Bakhshi H, Ostovaneh MR, et al. Temporal change in inflammatory biomarkers and risk of cardiovascular events: the Multi-ethnic Study of Atherosclerosis [published online ahead of print, 2021 Jul 9]. ESC Heart Fail. 2021;10.1002/ehf2.13445....

NULL

Etemadifar M, Salari M, Kargaran PK, et al. Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study [published online ahead of print, 2021 Jul 5]. Mult Scler Relat Disord. 2021;54:103127. doi:10.1016/j.msard.2021.10312...

NULL

Ziaei H, Tonkaboni A, Shamshiri A, Rezaei N. "Oral Manifestations of Patients with Inherited Defect in Phagocyte Number or Function" a systematic review [published online ahead of print, 2021 Jul 13]. Clin Immunol. 2021;108796. doi:10.1016/j.clim.202...

NULL

Redwan EM, Alghamdi MF, El-Aziz TMA, et al. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19 [published online ahead of print, 2021 Jul 16]. Autoimmun Rev. 2021;20(10):102909. doi:10.1016/j.autrev.2021.102909

NULL

Lundstrom K, Barh D, Uhal BD, et al. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?. Biomolecules. 2021;11(7):1020. Published 2021 Jul 13. doi:10.3390/biom11071020

NULL

Filgueiras IS, Torrentes de Carvalho A, Cunha DP, et al. The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations. PLoS Negl Trop Dis. 2021;15(8):e0009575. Published 2021 Aug 5. doi:10.1371/journal.p...

NULL

Sazgarnejad, Saharnaz et al. “Anti-inflammatory Effects of GLP-1 in Patients with COVID-19.” Expert review of anti-infective therapy, 10.1080/14787210.2021.1964955. 4 Aug. 2021, doi:10.1080/14787210.2021.1964955

NULL

Nowroozi, Mohammad Reza et al. “The role of nutritional interventions in prostate cancer: A review.” Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 26 29. 27 May. 2021, doi:10.4103/jrms.J...

NULL

Etemadifar M, Aghababaei A, Nouri H, Kargaran PK, Mohammadi S, Salari M. Autoimmune encephalitis: the first observational study from Iran [published online ahead of print, 2021 Jul 30]. Neurol Sci. 2021;10.1007/s10072-021-05400-1. doi:10.1007/s10072-...

NULL

Momtazmanesh S, Rezaei N. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. Front Oncol. 2021;11:712786. Published 2021 Jul 12. doi:10.3389/fonc.2021.712786

NULL

Adibi I, Najafi A, Merajifar F, et al. Quantitative Magnetic Resonance Imaging Analysis of Early Markers of Upper Cervical Cord Atrophy in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Mult Scler Int. 2021;2021:9917582. Published 202...

NULL

Farshbafnadi M, Agah E, Rezaei N. The second brain: The connection between gut microbiota composition and multiple sclerosis. J Neuroimmunol. 2021 Aug 24;360:577700. doi: 10.1016/j.jneuroim.2021.577700. Epub ahead of print. PMID: 34482269.

NULL

Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The Role of Type I Interferon in the Treatment of COVID-19. J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27317. Epub ahead of print. PMID: 34468995.

NULL

Ghaffari S, Khalili N, Rezaei N. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy. J Exp Clin Cancer Res. 2021 Aug 26;40(1):269. doi: 10.1186/s13046-021-02076-5. PMID: 34446084; PMCID: PMC8390258.

NULL

Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292. Epub ahead of print. PMID: 34427929.

NULL

Mahdiabadi S, Momtazmanesh S, Perry G, Rezaei N. Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review. Rev Neurosci. 2021 Sep 10. doi: 10.1515/revneuro-2021-0092. Epub ahead of print. PMID: 34506700.

NULL

Eftekhar SP, Yazdanpanah N, Rezaei N. Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management. Expert Rev Anticancer Ther. 2021 Sep 13. doi: 10.1080/14737140.2021.1979396. Epub ahead of print. PM...

NULL

Elrashdy F, Tambuwala MM, Hassan SS, Adadi P, Seyran M, El-Aziz TMA, Rezaei N, Lal A, Aljabali AAA, Kandimalla R, Bazan NG, Azad GK, Sherchan SP, Choudhury PP, Serrano-Aroca Á, Takayama K, Chauhan G, Pizzol D, Barh D, Panda PK, Mishra YK, Palù G, Lun...

NULL

Zamani R, Pouremamali R, Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci. 2021 Sep 17. doi: 10.1515/revneuro-202...

NULL

Davoodi L, Jafarpour H, Oladi Z, Zakariaei Z, Tabarestani M, Ahmadi BM, Razavi A, Hessami A. Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial. Int J Cardiol Heart Vasc. 2021 Oct;36:100875. doi: 10.1016/j....

NULL

Hosseini M, Habibi Z, Hosseini N, Abdoli S, Rezaei N. Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review. Expert Opin Biol Ther. 2021 Sep 19. doi: 10.1080/14712598.2021.1983539. Epub ahead...

NULL

Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Deliv Transl Res. 20...

NULL

Bahreini F, Jabbari P, Gossing W, Aziziyan F, Frohme M, Rezaei N. The role of noncoding RNAs in pituitary adenoma [published online ahead of print, 2021 Sep 24]. Epigenomics. 2021;10.2217/epi-2021-0165. doi:10.2217/epi-2021-0165

NULL

Keshavarz P, Haseli S, Yazdanpanah F, Bagheri F, Raygani N, Karimi-Galougahi M. A Systematic Review of Imaging Studies in Olfactory Dysfunction Secondary to COVID-19 [published online ahead of print, 2021 Aug 30]. Acad Radiol. 2021;S1076-6332(21)0036...

NULL

Hassan SS, Lundstrom K, Barh D, et al. Implications derived from S-protein variants of SARS-CoV-2 from six continents [published online ahead of print, 2021 Sep 24]. Int J Biol Macromol. 2021;S0141-8130(21)02005-5. doi:10.1016/j.ijbiomac.2021.09.080

NULL

Keshavarz P, Azrumelashvili T, Yazdanpanah F, et al. Percutaneous catheter drainage of pancreatic associated pathologies: A systematic review and meta-analysis [published online ahead of print, 2021 Sep 28]. Eur J Radiol. 2021;144:109978. doi:10.1016...

NULL

Mansouri V, Yazdanpanah N, Rezaei N. The immunologic aspects of cytokine release syndrome and graft versus host disease following CAR T cell therapy [published online ahead of print, 2021 Oct 5]. Int Rev Immunol. 2021;1-20. doi:10.1080/08830185.2021....

NULL

Ebrahimi Meimand S, Pour-Rashidi A, Masoumi Shahrbabak M, Mohammadi E, Ebrahimi Meimand F, Rezaei N. The prognostication potential of BRCA genes expression in gliomas: a genetic survival analysis study [published online ahead of print, 2021 Oct 1]. W...

NULL

Kolahchi Z, Sohrabi H, Ekrami Nasab S, Jelodari Mamaghani H, Keyfari Alamdari M, Rezaei N. Potential therapeutic approach of intravenous immunoglobulin against COVID-19. Allergy Asthma Clin Immunol. 2021;17(1):105. Published 2021 Oct 9. doi:10.1186/s...

NULL

Hessami A, Rezaei N. Cardiovascular diseases burden in COVID-19 [published online ahead of print, 2021 Oct 2]. Am J Emerg Med. 2021;S0735-6757(21)00803-2. doi:10.1016/j.ajem.2021.09.066

NULL

Ariamanesh M, Porouhan P, PeyroShabany B, et al. Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy [published online ahead of print, 2021 Oct 11]. Cancer Invest. 2021;1-12. doi:10.1080/07357907.2...

NULL

Salgado RC, Fonseca DLM, Marques AHC, et al. The network interplay of interferon and Toll-like receptor signaling pathways in the anti-Candida immune response. Sci Rep. 2021;11(1):20281. Published 2021 Oct 13. doi:10.1038/s41598-021-99838-0

NULL

Adibfar S, Elveny M, Kashikova HS, et al. The molecular mechanisms and therapeutic potential of EZH2 in breast cancer [published online ahead of print, 2021 Oct 12]. Life Sci. 2021;120047. doi:10.1016/j.lfs.2021.120047

NULL

Khedri M, Zandi P, Ghasemy E, Nikzad A, Maleki R, Rezaei N. In-silico study on perovskites application in capturing and distorting coronavirus. Inform Med Unlocked. 2021;26:100755. doi:10.1016/j.imu.2021.100755

NULL

Heidari A, Rostam-Abadi Y, Rezaei N. The immune system and autism spectrum disorder: association and therapeutic challenges. Acta Neurobiol Exp (Wars). 2021;81(3):249-263. doi:10.21307/ane-2021-023

NULL

Javadinia SA, Ariamanesh M, Nabavifard M, et al. Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after one year of the COVID-19 Pandemic [published online ahead of print, 2021 Oct 26]. Ca...

NULL

Baharlooi H, Mansourabadi AH, Minbashi Moeini M, Mohamed Khosroshahi L, Azimi M. Nucleic Acids as Novel Therapeutic Modalities to Address Multiple Sclerosis Onset and Progression [published online ahead of print, 2021 Oct 25]. Cell Mol Neurobiol. 202...

NULL

Samimi N, Farjam M, Klionsky DJ, Rezaei N. The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types [published online ahead of print, 2021 Oct 28]. Autophagy. 2021;1-4. doi:10.1080/15548627.2021.1989150

NULL

Khanmohammadi S, Rezaei N, Khazaei M, Shirkani A. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19 [published online ahead of print, 2021 Oct 28]. J Clin Immunol. 2021;10.1007/s10875-02...

NULL

Mirjalili SZ, Sabourian R, Sadeghalvad M, Rezaei N. Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders [published online ahead of print, 2021 Nov 3]. Int...

NULL

Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Front Immunol. 2021;12:741061. Published 2021 Oct 22. doi:10.3389/fimmu.2021.741061

NULL

Madani S, Zandieh F, Ahmadi M, Parvizi M, Rezaei N. Does the reaction size of skin prick test associated with the allergic rhinitis symptom severity?. Allergol Immunopathol (Madr). 2021;49(6):60-62. Published 2021 Nov 1. doi:10.15586/aei.v49i6.211

NULL

Aleebrahim-Dehkordi E, Molavi B, Mokhtari M, et al. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses [published online ahead of print, 2021 Nov 10]. Transpl Immunol. 2021;70:101...

NULL

Moeinafshar A, Yazdanpanah N, Rezaei N. Diagnostic biomarkers of dilated cardiomyopathy [published online ahead of print, 2021 Nov 8]. Immunobiology. 2021;226(6):152153. doi:10.1016/j.imbio.2021.152153

NULL

Shahin T, Kuehn HS, Shoeb MR, et al. Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. Sci Immunol. 2021;6(65):eabe3981. doi:10.1126/sciimmunol.abe3981

NULL

Esmaeilzadeh A, Bahmaie N, Nouri E, Hajkazemi MJ, Zareh Rafie M. Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study. Int J Mol Sci. 2021;22(22):12552. Published 2021 Nov 21...

NULL

Mueller AL, Payandeh Z, Mohammadkhani N, et al. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells. 2021;10(11):3017. Published 2021 Nov 4. doi:10.3390/cells10113017

NULL

Pourriyahi H, Yazdanpanah N, Saghazadeh A, Rezaei N. Loneliness: An Immunometabolic Syndrome. Int J Environ Res Public Health. 2021;18(22):12162. Published 2021 Nov 19. doi:10.3390/ijerph182212162

NULL

Etemadifar M, Nouri H, Maracy MR, et al. Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis [published online ahead of print, 2021 Nov 4]. Rev Neurol (Paris). 2021;S0035-3787(21)00743-8. doi:10.1...

NULL

Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H. Movement Disorders Associated with COVID-19. Parkinsons Dis. 2021;2021:3227753. Published 2021 Nov 8. doi:10.1155/2021/3227753

NULL

Kaveh MH, Faradonbeh MR, Kaveh S. Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis [published online ahead of print, 2021 Nov 18]. J Te...

NULL

Kouhi A, Shakeri S, Yazdani N, et al. Association of Pro-inflammatory Cytokine Gene Polymorphism with Meniere's Disease in an Iranian Sample. Iran J Allergy Asthma Immunol. 2021;20(6):734-739. Published 2021 Dec 8. doi:10.18502/ijaai.v20i6.8024

NULL

Zinatizadeh MR, Zarandi PK, Zinatizadeh M, Yousefi MH, Amani J, Rezaei N. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines [published online ahead of print, 2021 Dec 10]. Biomed Pharmacother. 2021;146:112527. doi:10.1016/j...

NULL

Etemadifar M, Sedaghat N, Nouri H, et al. SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine [published online ahead of pri...

NULL

Mojtahedi H, Yazdanpanah N, Rezaei N. Chronic myeloid leukemia stem cells: targeting therapeutic implications. Stem Cell Res Ther. 2021;12(1):603. Published 2021 Dec 18. doi:10.1186/s13287-021-02659-1

NULL

Prates-Syed WA, Chaves LCS, Crema KP, et al. VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants. Vaccines (Basel). 2021;9(12):1409. Published 2021 Nov 30. doi:10.3390/vaccines9121409

NULL

Freire PP, Cury SS, Lopes LO, et al. Decreased miR-497-5p Suppresses IL-6 Induced Atrophy in Muscle Cells. Cells. 2021;10(12):3527. Published 2021 Dec 14. doi:10.3390/cells10123527

NULL

Mardani M, Rashedi S, Keykhaei M, et al. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis [published online ahead of print, 2021 Nov 29]. Pathol Res Pract. 2021;229:1537...

NULL

Soltani Khaboushan A, Yazdanpanah N, Rezaei N. Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis [published online ahead of print, 2022 Jan 11]. Mol Neurobiol. 2022;10.1007/s12035-022-02725-6. doi:10.1007/s12035-022-02725-6

NULL

Zeynali Bujani M, Behnampour M, Rahimi N, et al. The Effect of Influenza Vaccination on COVID-19 Morbidity, Severity and Mortality: Systematic Review and Meta-Analysis. Malays J Med Sci. 2021;28(6):20-31. doi:10.21315/mjms2021.28.6.3

NULL

Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N. Stem cell transplantation as a progressing treatment for retinitis pigmentosa [published online ahead of print, 2022 Jan 10]. Cell Tissue Res. 2022;10.1007/s00441-021-03551-3. doi:10....

NULL

Davoodvandi A, Fallahi F, Tamtaji OR, et al. An Update on the Effects of Probiotics on Gastrointestinal Cancers. Front Pharmacol. 2021;12:680400. Published 2021 Dec 21. doi:10.3389/fphar.2021.680400

NULL

França TT, Barreiros LA, Salgado RC, et al. CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics [published online ahead of print, 2022 Jan 4]. J Clin Immunol. 2022;10.1007/s10875-021-01182-5. doi:10.1007/s108...

NULL

Tonkaboni A, Ziaei H, Rezaei N. Teledentistry during COVID-19. Int J Clin Pract. 2021;75(12):e15013. doi:10.1111/ijcp.15013

NULL

Rahmani S, Rezaei N. Omicron (B.1.1.529) variant: Development, dissemination, and dominance [published online ahead of print, 2021 Dec 29]. J Med Virol. 2021;10.1002/jmv.27563. doi:10.1002/jmv.27563

NULL

Alimohammadi E, Nikzad A, Khedri M, et al. Molecular Tuning of the Nano-Bio Interface: Alpha-Synuclein's Surface Targeting with Doped Carbon Nanostructures. ACS Appl Bio Mater. 2021;4(8):6073-6083. doi:10.1021/acsabm.1c00421

NULL

França TT, Barreiros LA, Salgado RC, et al. Correction to: CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics [published online ahead of print, 2022 Feb 7]. J Clin Immunol. 2022;10.1007/s10875-022-01221-9. d...

NULL

Khanmohammadi S, Shad TM, Delavari S, et al. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia [published online ahead of print, 2022 Feb 8]. Endocr Metab Immune Disord Drug Targets. 2022;10...

NULL

Sharif PM, Nematizadeh M, Saghazadeh M, Saghazadeh A, Rezaei N. Computed tomography scan in COVID-19: a systematic review and meta-analysis. Pol J Radiol. 2022;87:e1-e23. Published 2022 Jan 5. doi:10.5114/pjr.2022.112613

NULL

Hassan SS, Choudhury PP, Dayhoff GW 2nd, et al. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2. Arch Biochem Biophys. 2022;717:109124. doi:10.1016/j.abb.2022.109124

NULL

Torabi S, Bahreini F, Rezaei N. Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 [published online ahead of print, 2022 Jan 27]. Infect Disord Drug Targets. 2022;10.2174/1871526522666220127120617. doi:10.2174/187152652266622...

NULL

Moeini Shad T, Yazdani R, Amirifar P, et al. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature. Front Immunol. 2022;12:779502. Published 2022 Jan 14. doi:10.3389/fimmu.2021.779502

NULL

Ebrahimi M, Balibegloo M, Rezaei N. Monoclonal antibodies in diabetic retinopathy [published online ahead of print, 2022 Feb 1]. Expert Rev Clin Immunol. 2022;10.1080/1744666X.2022.2037420. doi:10.1080/1744666X.2022.2037420

NULL

Sadeghmousavi S, Shahkarami S, Rayzan E, et al. A 3-year- old boy with an Xp21 deletion syndrome: A case report [published online ahead of print, 2022 Feb 1]. Endocr Metab Immune Disord Drug Targets. 2022;10.2174/1871530322666220201143656. doi:10.217...

NULL

Zalpoor H, Akbari A, Samei A, et al. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett. 2022;27(1):10. Pub...

NULL

Makuku R, Seyedmirzaei H, Tantuoyir MM, et al. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article [published online ahead of print, 2022 Feb 1]. Int Immunopharmacol. 2022;105:10858...

NULL

Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N. Stem cell transplantation as a progressing treatment for retinitis pigmentosa. Cell Tissue Res. 2022;387(2):177-205. doi:10.1007/s00441-021-03551-3

NULL

Etemadifar M, Abhari AP, Nouri H, Salari M, Maleki S, Amin A, Sedaghat N. Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC Neurol. 2022 Feb 22;22(1):64. doi: 10.1186/s12883-022-02590-9...

NULL

Mirzayi P, Shobeiri P, Kalantari A, Perry G, Rezaei N. Optogenetics: implications for Alzheimer's disease research and therapy. Mol Brain. 2022 Feb 23;15(1):20. doi: 10.1186/s13041-022-00905-y. PMID: 35197102; PMCID: PMC8867657.

NULL

Etemadifar M, Abhari AP, Nouri H, Sigari AA, Piran Daliyeh SM, Maracy MR, Salari M, Maleki S, Sedaghat N. Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. Hum Vaccin Immunother. 2022 Fe...

NULL

Etemadifar M, Nouri H, Salari M, Sedaghat N. Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse. Hum Vaccin Imm...

NULL

Shobeiri P, Karimi A, Momtazmanesh S, Teixeira AL, Teunissen CE, van Wegen EEH, Hirsch MA, Yekaninejad MS, Rezaei N. Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic rev...

NULL

Samami E, Pourali G, Arabpour M, Fanipakdel A, Shahidsales S, Javadinia SA, Hassanian SM, Mohammadparast S, Avan A. The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational an...

NULL

Duarte-Silva E, Oriá AC, Mendonça IP, de Melo MG, Paiva IHR, Maes M, Joca SRL, Peixoto CA. Tiny in size, big in impact: Extracellular vesicles as modulators of mood, anxiety and neurodevelopmental disorders. Neurosci Biobehav Rev. 2022 Feb 16;135:104...

NULL

Jamshidi E, Asgary A, Shafiekhani P, et al. Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines [published online ahead of print, 2022 Apr 13]. Hum Vaccin Immunother. 2022;1-10. doi:10.1080/...

NULL

Haghshomar M, Shobeiri P, Brand S, Rossell SL, Akhavan Malayeri A, Rezaei N. Changes of symptoms of eating disorders (ED) and their related psychological health issues during the COVID-19 pandemic: a systematic review and meta-analysis. J Eat Disord....

NULL

Sisakht AK, Malekan M, Ghobadinezhad F, et al. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment [published online ahead of print, 2022 Apr 11]. Cell Mol Neurobiol. 2022;10.1007/s10571-022-01212-9. doi:10.1007/s10571-022-012...

NULL

Karami Fath M, Babakhaniyan K, Zokaei M, et al. Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell Mol Biol Lett. 2022;27(1):33. Published 2022 Apr 9. doi:10.1186/s11658-022-00332-w

NULL

Danandeh K, Jabbari P, Rayzan E, et al. Novel NFkB mutation in a case of lymphoproliferative disorder case report [published online ahead of print, 2022 Apr 7]. Endocr Metab Immune Disord Drug Targets. 2022;10.2174/1871530322666220407091356. doi:10.2...

NULL

Zalpoor H, Akbari A, Nabi-Afjadi M. Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases [published online ahead of print, 2022 Apr 4]. Hum Cell. 2022;1-3. do...

NULL

Yazdanpanah F, Iranpour P, Haseli S, Poursadeghfard M, Yarmahmoodi F. Acute disseminated encephalomyelitis (ADEM) after SARS- CoV-2 vaccination: A case report. Radiol Case Rep. 2022;17(5):1789-1793. Published 2022 Mar 26. doi:10.1016/j.radcr.2022.03....

NULL

Gharehzadehshirazi A, Amini A, Rezaei N. Hyper IgE syndromes: A clinical approach. Clin Immunol. 2022;237:108988. doi:10.1016/j.clim.2022.108988

NULL

Fayyaz F, Yazdanpanah N, Rezaei N. Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer. Cell Commun Signal. 2022;20(1):41. Published 2022 Mar 28. doi:10.1186/s12964-022-00836-0

NULL

Shobeiri P, Kalantari A, Teixeira AL, Rezaei N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol Sex Differ. 2022;13(1):12. Published 2022 Mar 25. doi:...

NULL

Aliasin MM, Yazdanpanah N, Rezaei N. Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines - where do we stand? [published online ahead of print, 2022 Mar 25]. Rev Neurosci. 2022;10.1515/revneuro-2022-0006. doi:10.1515/revneuro-2...

NULL

Yousefi H, Gholami M, Zoughi M, et al. Role of genetic polymorphisms in recurrent aphthous stomatitis: A systematic review and meta-analysis. Cytokine. 2022;153:155864. doi:10.1016/j.cyto.2022.155864

NULL

Zalpoor H, Bakhtiyari M, Liaghat M, Nabi-Afjadi M, Ganjalikhani-Hakemi M. Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α) [published onlin...

NULL

Saghazadeh A, Rezaei N. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis. J Interferon Cytokine Res. 2022;42(3):95-107. doi:10.1089/jir.2021.0176

NULL

Schimke LF, Marques AHC, Baiocchi GC, et al. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States. Cells. 2022;11(5):847. Published 2022 Mar 1. doi:10.3390/cells11050847

NULL

Haghi Ashtiani MT, Sadeghi Rad P, Asnaashari K, Shahhosseini A, Berenji F, Mamishi S. Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study. PLoS One. 2022;17(4):e0266923. Published 2022 Apr 14. doi:10.1371/journal.pon...

NULL

Cabral-Marques O, Halpert G, Schimke LF, et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun. 2022;13(1):1220. Published 2022 Mar 9. doi:10.1038/s41467-022-28905-5

NULL

Congress

8th International Conference on Immunodeficiency Diseases (April 23rd-24th, 2016)

NULL

Book

Rezaei N. Cancer Immunotherapy for Organ-Specific Tumors

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume focuses on the immunopathology and immunotherapy of organ cancers in detail. It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers, bone and connective tissue tumors, central nervous system tumors, lung cancers, genitourinary tract tumors and breast cancers. In so doing, it builds on the previous two volumes in Cancer Immunology, placing basic knowledge on tumor immunology and immunotherapy into a clinical perspective with the aim of educating clinicians on advances in cancer immunology and the most recent approaches in the immunotherapy of various tumors. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists. This book has 24 chapters.

Primary Immunodeficiency Diseases.Definition, Diagnosis, and Management Editors: Rezaei, Nima, Aghamohammadi, Asghar, Notarangelo, Luigi D.

The number of diagnosed cases of primary immunodeficiency diseases (PIDs) – a group of inborn disorders of the immune system – is growing rapidly, but misdiagnosis or late diagnosis still occurs in a significant number of patients, with serious consequences. This is the second edition of a practical reference textbook on PIDs that has been widely welcomed by scientists and clinicians from around the world. The new edition has been extensively revised to reflect advances in knowledge and includes various PIDs not previously covered. For each disease, information is provided on definition, etiology, clinical manifestations, diagnosis, and management. This book will represent an ideal resource for specialists when engaging in diagnosis, clinical decision-making, and treatment planning. It will also prove invaluable for doctors in training and other physicians and nurses who wish to learn more about PIDs.

Rezaei N. Physiology and Pathology of Immunology, 2018, InTech (ISBN 978-953-51-3691-0)

Having authored and published many successful and important textbooks in primary immunodeficiencies and cancer immunology, the editor of Physiology and Pathology of Immunology has ensured the high standard of writing and authenticity of the contents in this publication. The current book covers a spectrum of high-impact knowledge on the complex interplay between the environment, genes, and immunity that culminates in a generation of notorious processes of immune-related disorders. From evolution of regulatory T-cell function, gigantic cytokine networks within the human body to host-pathogen interactions of Chagas disease and Parkinson's disease, the Physiology and Pathology of Immunology goes further to decipher new codes from the immunity enigma, making it essential for experienced and new learners who wish to join the galaxy of modern immunology.

Rezaei N. Pediatric Allergy - A Case-Based Collection with MCQs, Volume 1, 2019, Springer (978-3-030-18281-6)

NULL

Rezaei N. Pediatric Immunology - A Case-Based Collection with MCQs, Volume 2, 2019, Springer (ISBN 978-3-030-21261-2)

This book comprises a collection of categorized case-based questions, directed and meticulously selected to cover the most common and most important aspects of immunodeficiency diseases. Immunodeficiency disorders of infancy and childhood such as antibody deficiencies, phagocyte defects and defects in innate immunity are addressed among others. Each chapters starts with a brief of the initial presentation and lab data of the patient, followed by a series of 5-6 multiple choice questions (MCQs), leading the reader to the diagnosis and best of practice in a step-wise manner. This MCQ format along with precise, yet detailed answer ensures a quick, case-based, reality learning to the reader. This comprehensive MCQ series, is an essential reading material that a pediatric clinician, hematologist, immunologist, transplant specialist, or pulmonologist, can not afford to miss.

Rahmani F, Rezaei N. Pediatric Autoimmunity and Transplantation - A Case-Based Collection with MCQs, Volume 3, 2020, Springer (ISBN 978-3-030-26279-2)

NULL

Rezaei N. Cancer Immunology: A Translational Medicine Context, 2nd edition, 2020, Springer (ISBN 978-3-030-30844-5)

NULL

Rezaei N. Immunogenetics, 2019, InTech (ISBN 978-1-83880-347-6)

Because genetic factors can impact immune responses, and immunogenetic associations serve as a predictor of disease development and as a biological indicator of disease progression, the study of immunogenetics is important to basic genetics and immunology, as well as to translational and individualized medicine.This book addresses a few but important issues on the subject of immunogenetics. First, it will review the role that human leukocyte antigen molecules play in the immune system and then take into consideration the effectiveness of Western blotting for the detection of immunologic proteins. The book will discuss studies on the immunogenetics of cancer and tuberculosis followed by implications for immunotherapy. Working separately, the book will also provide evidence that the application of immunogenetics has improved our understanding of brain and behavior disorders.

Rezaei N. Thymus, 2020, InTech (ISBN 978-1-78985-133-5)

The thymus gland is highly valuable, due to its functions as a part of the neuroendocrine system as well as its actions to provide a primary lymphoid microenvironment that efficiently carries T-cell differentiation and selection. This book begins with an introduction and explanation of the development of the thymus. Subsequent chapters examine a range of conditions - including environmental pollution, congenital anomalies, autoimmune diseases, and malignancies - that threaten the function and development of the thymus. The information presented herein is useful for a wide range of readers across a variety of specialties.

Rezaei N. Toll-Like Receptors, 2019 (ISBN 978-1-78985-391-9)

Toll-like receptors (TLRs) are pattern recognition receptors that allow innate immunity to protect our body against invading pathogens. They are alsoregulators of adaptive immunity. The human TLR was discovered quite recently, but its functional significance is known worldwide and today TLR agonists have been approved for use in humans. This book provides an overview of TLRs and their role in parasitic infections and neurodegenerative diseases. It is hoped that it will encourage readers to seek out the latest developments in TLRs.

Mahdaviani A, Rezaei N. Pulmonary Manifestations of Primary Immunodeficiency Diseases, 2018, Springer (ISBN 978-303-00-0879-6)

This book provides a broad overview of the respiratory manifestations associated with Primary Immune deficiencies (PID) congenital genetic defects such as infections, chronic inflammation, autoimmunity, lymphoproliferation, allergic manifestations and rare forms of cancer. Since the most common site of involvement in PID is the lung, the pulmonologists (pediatrics or adult), Internists and General Practitioners may be among the first to recognize the pattern of pulmonary disorders, leading to diagnosis of PID. Pulmonary complications present a significant cause of morbidity and also mortality among patients suffering from different forms of PID. With the prevalence of lung infections and disease so high in PID patients, respiratory professionals will find this book to be an essential resource for diagnosing, managing and referring PID related pulmonary disorders in clinical practice.

Coronavirus Disease - COVID-19

In December 2019, the world witnessed the occurrence of a new coronavirus to humanity. The disease spread quickly and became known as a pandemic globally, affecting both society and the health care system, both the elderly and young groups of people, and both the men’s and women’s groups. It was a universal challenge that immediately caused a surge in scientific research. Be a part of a world rising in fighting against the pandemic, the Coronavirus Disease - COVID-19 was depicted in the early days of the pandemic, but updated by more than 200 scientists and clinicians to include many facets of this new infectious pandemic, including i, characteristics, ecology, and evolution of coronaviruses; ii, epidemiology, genetics, and pathogenesis (immune responses and oxidative stress) of the disease; iii, diagnosis, prognosis, and clinical manifestations of the disease in pediatrics, geriatrics, pregnant women, and neonates; iv, challenges of co-occurring the disease with tropical infections, cardiovascular diseases, hypertension, and cancer and to the settings of dentistry, hematology, ophthalmology, and pharmacy; v, transmission, prevention, and potential treatments, ranging from supportive ventilator support and nutrition therapy to potential virus- and host-based therapies, immune-based therapies, photobiomodulation, antiviral photodynamic therapy, and vaccines; vi, the resulting consequences on social lives, mental health, education, tourism industry and economy; and vii, multimodal approaches to solve the problem by bioinformatic methods, innovation and ingenuity, globalization, social and scientific networking, interdisciplinary approaches, and art integration. We are approaching December 2020 and the still presence of COVID-19, asking us to call it COVID (without 19).

Nuclear Medicine and Immunology

This book explores the close connection between immunology and nuclear medicine, which has led to radioimmunoimaging and radioimmunotherapy (RIT).

Translational Autoimmunity: Etiology of Autoimmune Diseases

Translational Autoimmunity: Etiology of Autoimmune Diseases is the first volume of the Translational Immunology book series. To attain its purpose as a detailed translational step to tackle autoimmunity, this volume sufficiently addresses basic questions on how the immune system is designed to distinguish self from nonself. It discusses the known mechanisms that lead to the maintenance of self-tolerance, presents potential triggers and malfunctions that impede normal immune processes, and demonstrates how the immune system induces an autoreactive state that results in the recognition of self-antigens seen in autoimmune conditions.

Translational Autoimmunity: Treatment of Autoimmune Diseases

Translational Autoimmunity: Treatment of Autoimmune Diseases, Volume Two in the Translational Immunology series, focuses on advances in therapeutic modalities in autoimmune diseases. Efficacy and safety of not only the current biologic therapies, but also novel drug targets are discussed. Therapeutic targeting of B regulatory cells, T regulatory cells, as well as the immunomodulation effects of nanoparticles and organisms are also covered, along with our understanding and future challenges of prognostic significance of treatments in autoimmune diseases.

Encyclopedia of Infection and Immunity

Four Volume Set provides new insights into the interactions between bacteria, fungi, parasites and their host innate and adaptive immune response. Comprised of over 200 chapters (3200 pages) written and edited by leading experts in the field, this book will serve as a key resource for students, researchers, academics and industry practitioners in the fields of microbiology, immunology, and infectious diseases.

Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features

Translational Autoimmunity: Autoimmune Diseases in Different Clinical Settings addresses autoimmunity and associated conditions, such as aging, infectious diseases, cancer, neurodegeneration, psychological disorders, fertility, inflammatory vascular diseases, and interstitial lung diseases. The book addresses sufficiently basic questions on how the immune system is designed to distinguish self from no self and behave such that it's able to maintain self-tolerance, how does it work in infections, and how it elicits an auto-reactive state and develops self-antigens seen in autoimmune conditions.

Translational Autoimmunity: Autoimmune Diseases in Different Organs

As the autoimmune diseases could affect different organs, Translational Autoimmunity: Autoimmune Diseases in Different Organs addresses the spectrum of autoimmune diseases. The fourth volume of Translational Immunology Series focuses on clinical and laboratory details of autoimmune diseases which are broadly categorized into two types of organ-specific autoimmune diseases and non-organ specific autoimmune diseases (also known as systemic autoimmune diseases). Autoimmune rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis, autoimmune rheumatic diseases such as diabetes mellitus and thyroid diseases, autoimmune neurologic diseases such as multiple sclerosis, as well as autoimmune hepatobiliary diseases, autoimmune renal diseases and autoimmune cutaneous diseases as the subject of discussion in Translational Autoimmunity: Autoimmune Diseases in Different Organs.

Translational Autoimmunity: Challenges for Autoimmune Diseases

Translational Autoimmunity: Challenges for Autoimmune Diseases, Fifth Edition addresses diagnostic approaches, therapeutic opportunities, and prognostic markers of different autoimmune diseases. This updated volume discusses autotoxicity, systems immunology, the prognostic significance of disease-specific autoantibodies, along with translational research to novel therapeutic policy in autoimmune diseases. From an introduction, to challenges and insights on the systems immunology of infectious and autoimmune diseases, new targets of treatments, and the role of autoantibodies in diagnosis and evolution, this book provides insights on many challenges researchers and clinicians are facing.

Translational Autoimmunity: Advances in Autoimmune Rheumatic Diseases

Translational Autoimmunity: Advances in Autoimmune Rheumatic Diseases, Volume Six addresses autoimmune diseases classified under the category of rheumatic diseases. Rheumatic diseases are heterogeneous groups of disorders in which inflammation affects not only joints, but also tendons, ligaments and bones. This updated release focuses on immunopathogenesis and clinical and laboratory details of rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, osteoarthritis and Sjogren’s syndrome, and will be of interest to researchers, students and clinicians interested in autoimmune diseases, especially rheumatic diseases.

Translational Neuroimmunology: Neuroinflammation

Translational NeuroImmunology: Neuroinflammation updates on bench to bedside studies on neurological disorders that have immunological etiologies. The book covers neuroimmunology and the principles of autoimmune and autoinflammatory neurological disorders, with multiple sclerosis as the main focus. The immunopathology, genetics and epigenetics, microbiome, diagnosis and treatment of multiple sclerosis will be explained in ten chapters. A chapter also examines distinct aspects of pericytes, with final discussions on the neurologic manifestations, diagnostic approaches and treatments of the various neuroimmune disorders and lessons learned from translational research on non-human primates and zebrafish.

Translational Neuroimmunology: Multiple Sclerosis

Translational Neuroimmunology: Multiple Sclerosis provides an update on bench to bedside studies on Multiple Sclerosis as an autoimmune disease. Divided into twelve chapters, the book begins with an in-depth introduction to the neuroimmunology and immunopathology of multiple sclerosis. Sections also provide content on genetics and epigenetics, the microbiome, diagnosis, and treatment of multiple sclerosis. Finally, various precision treatments are covered. All information is presented in an accessible, practical format, making this volume a valuable resource for immunologists, neurologists and researchers in translational biomedical research.